Attached files

file filename
8-K - FORM 8-K - OMEGA HEALTHCARE INVESTORS INCt1500726_8k.htm
EX-3.1 - EXHIBIT 3.1 - OMEGA HEALTHCARE INVESTORS INCt1500726_ex3-1.htm
EX-10.9 - EXHIBIT 10.9 - OMEGA HEALTHCARE INVESTORS INCt1500726_ex10-9.htm
EX-10.2 - EXHIBIT 10.2 - OMEGA HEALTHCARE INVESTORS INCt1500726_ex10-2.htm
EX-99.1 - EXHIBIT 99.1 - OMEGA HEALTHCARE INVESTORS INCt1500726_ex99-1.htm
EX-10.12 - EXHIBIT 10.12 - OMEGA HEALTHCARE INVESTORS INCt1500726_ex10-12.htm
EX-10.10 - EXHIBIT 10.10 - OMEGA HEALTHCARE INVESTORS INCt1500726_ex10-10.htm
EX-10.11 - EXHIBIT 10.11 - OMEGA HEALTHCARE INVESTORS INCt1500726_ex10-11.htm
EX-10.3 - EXHIBIT 10.3 - OMEGA HEALTHCARE INVESTORS INCt1500726_ex10-3.htm
EX-10.5 - EXHIBIT 10.5 - OMEGA HEALTHCARE INVESTORS INCt1500726_ex10-5.htm
EX-10.8 - EXHIBIT 10.8 - OMEGA HEALTHCARE INVESTORS INCt1500726_ex10-8.htm
EX-23.1 - EXHIBIT 23.1 - OMEGA HEALTHCARE INVESTORS INCt1500726_ex23-1.htm
EX-10.7 - EXHIBIT 10.7 - OMEGA HEALTHCARE INVESTORS INCt1500726_ex10-7.htm
EX-10.4 - EXHIBIT 10.4 - OMEGA HEALTHCARE INVESTORS INCt1500726_ex10-4.htm
EX-10.1 - EXHIBIT 10.1 - OMEGA HEALTHCARE INVESTORS INCt1500726_ex10-1.htm
EX-10.6 - EXHIBIT 10.6 - OMEGA HEALTHCARE INVESTORS INCt1500726_ex10-6.htm
EX-10.13 - EXHIBIT-10.13 - OMEGA HEALTHCARE INVESTORS INCt1500726_ex10-13.htm

 

Exhibit 99.2

 

INDEX TO THE FINANCIAL STATEMENTS

 

AVIV REIT, INC.

 

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP

 

         
Report of Independent Registered Public Accounting Firm with respect to Aviv REIT, Inc.     F-2  
Report of Independent Registered Public Accounting Firm with respect to Aviv REIT, Inc.     F-3  
Report of Independent Registered Public Accounting Firm with respect to Aviv Healthcare Properties Limited Partnership     F-4  
Report of Independent Registered Public Accounting Firm with respect to Aviv Healthcare Properties Limited Partnership     F-5  
Consolidated Balance Sheets as of December 31, 2014 and 2013 of Aviv REIT, Inc.     F-6  
Consolidated Statements of Operations and Comprehensive Income for the Years Ended December  31, 2014, 2013 and 2012 of Aviv REIT, Inc.     F-7  
Consolidated Statements of Changes in Equity for the Years Ended December  31, 2014, 2013 and 2012 of Aviv REIT, Inc.     F-8  
Consolidated Statements of Cash Flows for the Years Ended December  31, 2014, 2013 and 2012 of Aviv REIT, Inc.     F-9  
Consolidated Balance Sheets as of December  31, 2014 and 2013 of Aviv Healthcare Properties Limited Partnership     F-11  
Consolidated Statements of Operations and Comprehensive Income for the Years Ended December  31, 2014, 2013 and 2012 of Aviv Healthcare Properties Limited Partnership     F-12  
Consolidated Statements of Changes in Partners’ Capital for the Years Ended December  31, 2014, 2013 and 2012 of Aviv Healthcare Properties Limited Partnership     F-13  
Consolidated Statements of Cash Flows for the Years Ended December  31, 2014, 2013 and 2012 of Aviv Healthcare Properties Limited Partnership     F-14  
Notes to Consolidated Financial Statements     F-16  
   
FINANCIAL STATEMENT SCHEDULES        
   
Schedule II—Valuation and Qualifying Accounts     F-47  
Schedule III—Real Estate and Investments     F-48  

 

All other schedules for which provision is made in the applicable accounting regulation of the Securities and Exchange Commission are not required under the related instructions or are inapplicable or have been omitted because sufficient information has been included in the notes to the Consolidated Financial Statements.

 

F-1
  

 

AVIV REIT, INC.

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

The Board of Directors and the Stockholders

Aviv REIT, Inc.

 

We have audited the accompanying consolidated balance sheets of Aviv REIT, Inc. (the Company) as of December 31, 2014 and 2013, and the related consolidated statements of operations and comprehensive income, changes in equity, and cash flows for each of the three years in the period ended December 31, 2014. Our audits also included the financial statement schedules listed in the accompanying index to the financial statements. These financial statements and schedules are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements and schedules based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of the Company at December 31, 2014 and 2013, and the consolidated results of its operations and its cash flows for each of the three years in the period ended December 31, 2014, in conformity with U.S. generally accepted accounting principles. Also, in our opinion, the related financial statement schedules, when considered in relation to the basic financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.

 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the Company’s internal control over financial reporting as of December 31, 2014, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated February 26, 2015 expressed an unqualified opinion thereon.

 

/s/ Ernst & Young LLP
 
Chicago, Illinois
February 26, 2015

 

F-2
  

 

Report of Independent Registered Public Accounting Firm

 

The Board of Directors and the Stockholders

Aviv REIT, Inc.

 

We have audited Aviv REIT, Inc.’s (the Company) internal control over financial reporting as of December 31, 2014, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). The Company’s management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Assessment of Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit.

 

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

 

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2014, based on the COSO criteria.

 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of the Company as of December 31, 2014 and 2013 and the related consolidated statements of operations and comprehensive income, changes in equity, and cash flows for each of the three years in the period ended December 31, 2014, and our report dated February 26, 2015 expressed an unqualified opinion thereon.

 

/s/ Ernst & Young LLP
 
Chicago, Illinois
February 26, 2015

 

F-3
  

 

Report of Independent Registered Public Accounting Firm

 

The Board of Directors and the Partners

Aviv Healthcare Properties Limited Partnership

 

We have audited the accompanying consolidated balance sheets of Aviv Healthcare Properties Limited Partnership (the Partnership) as of December 31, 2014 and 2013, and the related consolidated statements of operations and comprehensive income, changes in partners’ capital, and cash flows for each of the three years in the period ended December 31, 2014. Our audits also included the financial statement schedules listed in the accompanying index to the financial statements. These financial statements and schedules are the responsibility of the Partnership’s management. Our responsibility is to express an opinion on these financial statements and schedules based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of the Partnership at December 31, 2014 and 2013, and the consolidated results of its operations and its cash flows for each of the three years in the period ended December 31, 2014, in conformity with U.S. generally accepted accounting principles. Also, in our opinion, the related financial statement schedules, when considered in relation to the basic financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.

 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the Partnership’s internal control over financial reporting as of December 31, 2014, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated February 26, 2015 expressed an unqualified opinion thereon.

 

/s/ Ernst & Young LLP
 
Chicago, Illinois
February 26, 2015

 

F-4
  

 

Report of Independent Registered Public Accounting Firm

 

The Board of Directors and the Partners

Aviv Healthcare Properties Limited Partnership

 

We have audited Aviv Healthcare Properties Limited Partnership’s (the Partnership) internal control over financial reporting as of December 31, 2014, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). The Partnership’s management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Assessment of Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Partnership’s internal control over financial reporting based on our audit.

 

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

 

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

In our opinion, the Partnership maintained, in all material respects, effective internal control over financial reporting as of December 31, 2014, based on the COSO criteria.

 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of the Partnership as of December 31, 2014 and 2013 and the related consolidated statements of operations and comprehensive income, changes in partners’ capital, and cash flows for each of the three years in the period ended December 31, 2014, and our report dated February 26, 2015 expressed an unqualified opinion thereon.

 

/s/ Ernst & Young LLP
 
Chicago, Illinois
February 26, 2015

 

F-5
  

 

AVIV REIT, INC.

Consolidated Balance Sheets

(in thousands except share data)

 

   December 31,
2014
   December 31,
2013
 
Assets          
Income producing property          
Land  $190,300   $138,150 
Buildings and improvements   1,845,992    1,138,173 
Assets under direct financing leases   11,291    11,175 
    2,047,583    1,287,498 
Less accumulated depreciation   (188,286)   (147,302)
Construction in progress and land held for development   23,150    23,292 
Net real estate   1,882,447    1,163,488 
Cash and cash equivalents   10,036    50,764 
Straight-line rent receivable, net   45,368    40,580 
Tenant receivables, net   4,095    1,647 
Deferred finance costs, net   19,024    16,643 
Loan receivables, net   42,697    41,686 
Other assets   16,763    15,625 
Total assets  $2,020,430   $1,330,433 
Liabilities and equity          
Secured loans  $193,418   $13,654 
Unsecured notes payable   652,292    652,752 
Line of credit   355,000    20,000 
Accrued interest payable   15,126    15,284 
Dividends and distributions payable       17,694 
Accounts payable and accrued expenses   18,582    10,555 
Tenant security and escrow deposits   26,259    21,586 
Other liabilities   9,805    10,463 
Total liabilities   1,270,482    761,988 
Equity:          
Stockholders’ equity          
Common stock (par value $0.01; 48,425,224 and 37,593,910 shares issued and outstanding, respectively)   484    376 
Additional paid-in capital   737,262    523,658 
Accumulated deficit   (119,039)   (89,742)
Total stockholders’ equity   618,707    434,292 
Noncontrolling interests—operating partnership   131,241    134,153 
Total equity   749,948    568,445 
Total liabilities and equity  $2,020,430   $1,330,433 

 

See accompanying notes.

 

F-6
  

 

AVIV REIT, INC.

Consolidated Statements of Operations and Comprehensive Income

(in thousands except share and per share data)

 

   Year Ended December 31 
   2014   2013   2012 
Revenues               
Rental income  $177,947   $136,513   $121,210 
Interest on loans and financing lease   4,483    4,400    4,633 
Interest and other income   1,612    154    1,129 
Total revenues   184,042    141,067    126,972 
Expenses               
Interest expense incurred   49,680    40,785    47,440 
Amortization of deferred financing costs   3,942    3,459    3,543 
Depreciation and amortization   44,023    33,226    26,892 
General and administrative   24,039    26,886    15,955 
Transaction costs   8,601    3,114    7,259 
Loss on impairment   2,341    500    11,117 
Reserve for uncollectible loans and other receivables   3,523    68    10,331 
Loss (gain) on sale of assets, net   2,518    (1,016)    
Loss on extinguishment of debt   501    10,974    28 
Other expenses           400 
Total expenses   139,168    117,996    122,965 
Income from continuing operations   44,874    23,071    4,007 
Discontinued operations           4,586 
Net income   44,874    23,071    8,593 
Net income allocable to noncontrolling interests—operating partnership   (9,082)   (6,010)   (3,455)
Net income allocable to common stockholders  $35,792   $17,061   $5,138 
Net income  $44,874   $23,071   $8,593 
Unrealized loss on derivative instruments           (476)
Total comprehensive income  $44,874   $23,071   $8,117 
Net income allocable to common stockholders  $35,792   $17,061   $5,138 
Unrealized loss on derivative instruments, net of noncontrolling interest—operating partnership portion of $0, $0, and $192, respectively           (284)
Total comprehensive income allocable to common stockholders  $35,792   $17,061   $4,854 
Earnings per common share:               
Basic:               
Income from continuing operations allocable to common stockholders  $0.80   $0.51   $0.12 
Discontinued operations, net of noncontrolling interests—operating partnership           0.14 
Net income allocable to common stockholders  $0.80   $0.51   $0.26 
Diluted:               
Income from continuing operations allocable to common stockholders  $0.77   $0.49   $0.12 
Discontinued operations, net of noncontrolling interests—operating partnership           0.14 
Net income allocable to common stockholders  $0.77   $0.49   $0.26 
Weighted average common shares outstanding:               
Basic   44,629,901    33,700,834    20,006,538 
Diluted   58,166,924    44,324,189    20,135,689 
Dividends declared per common share  $1.44   $1.40   $1.25 

 

See accompanying notes.

 

F-7
  

 

AVIV REIT, INC.

Consolidated Statements of Changes in Equity

(in thousands except share data)

 

   Stockholders’ Equity    Noncontrolling      
   Common Stock    Additional
Paid-In-
   Accumulated   Accumulated Other
Comprehensive Income
    Total
Stockholders’
    Interests—
Operating  
    Total   
   Shares   Amount   Capital   Deficit   (Loss)    Equity      Partnership      Equity   
Balance at January 1, 2012   15,831,368   $159   $264,804   $(21,383)  $(1,868)  $241,712   $5,546   $247,258 
Non-cash stock (unit)-based compensation           1,284            1,284    406    1,690 
Distributions to partners                           (15,638)   (15,638)
Capital contributions   5,822,445    58    108,942            109,000    358    109,358 
Unrealized loss on derivative instruments                   (284)   (284)   (192)   (476)
Dividends to stockholders               (30,282)       (30,282)       (30,282)
Net income               5,138        5,138    3,455    8,593 
Balance at December 31, 2012   21,653,813    217    375,030    (46,527)   (2,152)   326,568    (6,065)   320,503 
Non-cash stock (unit)-based compensation   23,250        10,864            10,864    888    11,752 
Shares issued for settlement of management vested stock   414,710    4    8,290            8,294        8,294 
Distributions to partners                           (16,658)   (16,658)
Capital contributions                           214    214 
Initial public offering proceeds   15,180,000    152    303,448            303,600        303,600 
Cost of raising capital           (25,829)           (25,829)       (25,829)
Retirement of derivative instrument                   2,152    2,152    1,622    3,774 
Dividends to stockholders               (60,276)       (60,276)       (60,276)
Reclassification of equity at IPO date           (153,751)           (153,751)   153,751     
Conversion of OP Units/Adjustment of noncontrolling interests—operating partnership ownership of operating partnership   322,137    3    5,606            5,609    (5,609)    
Net income               17,061        17,061    6,010    23,071 
Balance at December 31, 2013   37,593,910    376    523,658    (89,742)       434,292    134,153    568,445 
Non-cash stock-based compensation           4,861            4,861        4,861 
Shares issued for settlement of management vested stock and exercised options, net   287,406    3    1,704            1,707        1,707 
Distributions to partners                           (16,072)   (16,072)
Capital contributions                           60    60 
Proceeds from issuance of common stock   9,200,000    92    221,628            221,720        221,720 
Cost of raising capital           (10,558)           (10,558)       (10,558)
Dividends to stockholders               (65,089)       (65,089)       (65,089)
Conversion of OP Units   1,343,908    13    17,146            17,159    (17,159)    
Adjustment of noncontrolling interest-operating partnership ownership of operating partnership           (21,177)           (21,177)   21,177     
Net income               35,792        35,792    9,082    44,874 
Balance at December 31,2014   48,425,224   $484   $737,262   $(119,039)  $   $618,707   $131,241   $749,948 

 

See accompanying notes.

 

F-8
  

 

AVIV REIT, INC.

Consolidated Statements of Cash Flows

(in thousands)

 

   Year Ended December 31, 
   2014   2013   2012 
Operating activities               
Net income  $44,874   $23,071   $8,593 
Adjustments to reconcile net income to net cash provided by operating activities:               
Depreciation and amortization   44,023    33,226    26,935 
Amortization of deferred financing costs   3,942    3,459    3,543 
Accretion of debt premium   (539)   (507)   (414)
Straight-line rental income, net   (4,788)   (4,478)   (7,656)
Rental income from intangible amortization, net   (666)   (1,369)   (1,486)
Non-cash stock-based compensation   4,861    11,752    1,689 
Loss (gain) on sale of assets, net   2,518    (1,016)   (4,425)
Non-cash loss on extinguishment of debt   494    5,161    42 
Loss on impairment   2,341    500    11,117 
Reserve for uncollectible loan and other receivables   3,523    68    10,331 
Accretion of earn-out provision for previously acquired real estate investments           400 
Changes in assets and liabilities:               
Tenant receivables   (2,577)   (3,511)   (4,572)
Other assets   (1,123)   (5,229)   (5,873)
Accounts payable and accrued expenses   2,880    3,949    5,021 
Tenant security deposits and other liabilities   5,079    2,277    1,230 
Net cash provided by operating activities   104,842    67,353    44,475 
Investing activities               
Purchase of real estate   (706,970)   (197,388)   (172,773)
Proceeds from sales of real estate, net   2,277    15,549    31,933 
Capital improvements   (14,997)   (12,003)   (13,558)
Development projects   (43,083)   (18,738)   (28,067)
Loan receivables received from others   19,642    4,086    14,632 
Loan receivables funded to others   (24,376)   (10,407)   (16,857)
Net cash used in investing activities   (767,507)   (218,901)   (184,690)

 

See accompanying notes.

 

F-9
  

 

AVIV REIT, INC.

Consolidated Statements of Cash Flows (continued)

(in thousands)

 

   Year Ended December 31, 
   2014   2013   2012 
Financing activities               
Borrowings of debt  $668,000   $470,000   $267,761 
Repayment of debt   (153,157)   (488,241)   (174,127)
Payment of financing costs   (6,980)   (10,448)   (5,143)
Capital contributions   60    575    109,000 
Deferred contribution           (35,000)
Proceeds from issuance of common stock   221,720    303,600     
Cost of raising capital   (10,558)   (25,829)    
Shares issued from settlement of vested stock and exercised stock options, net   1,707         
Cash distributions to partners   (20,215)   (16,314)   (16,484)
Cash dividends to stockholders   (78,640)   (48,907)   (28,778)
Net cash provided by financing activities   621,937    184,436    117,229 
Net (decrease) increase in cash and cash equivalents   (40,728)   32,888    (22,986)
Cash and cash equivalents:               
Beginning of year   50,764    17,876    40,862 
End of year  $10,036   $50,764   $17,876 
Supplemental cash flow information               
Cash paid for interest  $50,972   $40,008   $46,711 
Supplemental disclosure of noncash activity               
Accrued dividends payable to stockholders  $   $13,551   $9,888 
Accrued distributions payable to partners  $   $4,143   $3,799 
Write-off of straight-line rent receivable, net  $1,549   $2,887   $1,552 
Write-off of in-place lease intangibles, net  $   $   $19 
Write-off of deferred financing costs, net  $501   $5,161   $42 
Assumed debt  $   $   $11,460 

 

See accompanying notes.

 

F-10
  

 

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP

 

Consolidated Balance Sheets

 

(in thousands)

 

   December 31, 
   2014   2013 
Assets          
Income producing property          
Land  $190,300   $138,150 
Buildings and improvements   1,845,992    1,138,173 
Assets under direct financing leases   11,291    11,175 
    2,047,583    1,287,498 
Less accumulated depreciation   (188,286)   (147,302)
Construction in progress and land held for development   23,150    23,292 
Net real estate   1,882,447    1,163,488 
Cash and cash equivalents   10,036    50,764 
Straight-line rent receivable, net   45,368    40,580 
Tenant receivables, net   4,095    1,647 
Deferred finance costs, net   19,024    16,643 
Loan receivables, net   42,697    41,686 
Other assets   16,763    15,625 
Total assets  $2,020,430   $1,330,433 
Liabilities and partners’ capital          
Secured loans  $193,418   $13,654 
Unsecured notes payable   652,292    652,752 
Line of credit   355,000    20,000 
Accrued interest payable   15,126    15,284 
Distributions payable       17,694 
Accounts payable and accrued expenses   18,582    10,555 
Tenant security and escrow deposits   26,259    21,586 
Other liabilities   9,805    10,463 
Total liabilities   1,270,482    761,988 
Partners’ capital:          
Partners’ capital   749,948    568,445 
Total liabilities and partners’ capital  $2,020,430   $1,330,433 

 

See accompanying notes.

 

F-11
  

 

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP

 

Consolidated Statements of Operations and Comprehensive Income

 

(in thousands except unit and per unit data)

 

   Year Ended December 31, 
   2014   2013   2012 
Revenues               
Rental income  $177,947   $136,513   $121,210 
Interest on loans and financing lease   4,483    4,400    4,633 
Interest and other income   1,612    154    1,129 
Total revenues   184,042    141,067    126,972 
Expenses               
Interest expense incurred   49,680    40,785    47,440 
Amortization of deferred financing costs   3,942    3,459    3,543 
Depreciation and amortization   44,023    33,226    26,892 
General and administrative   24,039    26,886    15,955 
Transaction costs   8,601    3,114    7,259 
Loss on impairment   2,341    500    11,117 
Reserve for uncollectible loans and other receivables   3,523    68    10,331 
Loss (gain )on sale of assets, net   2,518    (1,016)    
Loss on extinguishment of debt   501    10,974    28 
Other expenses           400 
Total expenses   139,168    117,996    122,965 
Income from continuing operations   44,874    23,071    4,007 
Discontinued operations           4,586 
Net income allocable to units  $44,874   $23,071   $8,593 
Net income allocable to units  $44,874   $23,071   $8,593 
Unrealized loss on derivative instruments           (476)
Total comprehensive income allocable to units  $44,874   $23,071   $8,117 
Earnings per unit:               
Basic:               
Income from continuing operations allocable to units  $0.80   $0.51   $0.12 
Discontinued operations           0.14 
Net income allocable to units  $0.80   $0.51   $0.26 
Diluted:               
Income from continuing operations allocable to units  $0.77   $0.49   $0.12 
Discontinued operations           0.14 
Net income allocable to units  $0.77   $0.49   $0.26 
Weighted average units outstanding:               
Basic   55,957,950    42,792,808    20,006,538 
Diluted   58,166,924    44,324,189    20,135,689 
Distributions declared per unit  $1.44   $1.40   $1.25 

 

See accompanying notes.

 

F-12
  

 

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP

 

Consolidated Statements of Changes in Partners’ Capital

(in thousands)

 

       Accumulated Other     
   Partners’
Capital
   Comprehensive
Income (Loss)
   Total 
Balance at January 1, 2012  $250,555   $(3,298)  $247,257 
Non-cash stock (unit)-based compensation   1,690        1,690 
Distributions to partners   (45,920)       (45,920)
Capital contributions   109,358        109,358 
Unrealized loss on derivative instruments       (476)   (476)
Net income   8,593        8,593 
Balance at December 31, 2012   324,276    (3,774)   320,502 
Non-cash stock (unit)-based compensation   11,752        11,752 
Units issued for settlement of management vested stock   8,294        8,294 
Distributions to partners   (76,934)       (76,934)
Capital contributions   215        215 
Initial public offering proceeds   303,600        303,600 
Cost of raising capital   (25,829)       (25,829)
Retirement of derivative instruments       3,774    3,774 
Net income   23,071        23,071 
Balance at December 31, 2013   568,445        568,445 
Non-cash stock (unit)-based compensation   4,861        4,861 
Units issued for settlement of management vested stock and exercised unit options, net   1,707        1,707 
Distributions to partners   (81,161)       (81,161)
Capital contributions   60        60 
Proceeds from issuance of common stock   221,720        221,720 
Cost of raising capital   (10,558)       (10,558)
Net income   44,874        44,874 
Balance at December 31, 2014  $749,948   $   $749,948 

 

See accompanying notes.

 

F-13
  

 

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP

 

Consolidated Statements of Cash Flows

 

(in thousands)

 

   Year Ended December 31, 
   2014   2013   2012 
Operating activities               
Net income  $44,874   $23,071   $8,593 
Adjustments to reconcile net income to net cash provided by operating activities:               
Depreciation and amortization   44,023    33,226    26,935 
Amortization of deferred financing costs   3,942    3,459    3,543 
Accretion of debt premium   (539)   (507)   (414)
Straight-line rental income, net   (4,788)   (4,478)   (7,656)
Rental income from intangible amortization, net   (666)   (1,369)   (1,486)
Non-cash stock-based compensation   4,861    11,752    1,689 
Loss (gain) on sale of assets, net   2,518    (1,016)   (4,425)
Non-cash loss on extinguishment of debt   494    5,161    42 
Loss on impairment   2,341    500    11,117 
Reserve for uncollectible loans and other receivables   3,523    68    10,331 
Accretion of earn-out provision for previously acquired real estate investments           400 
Changes in assets and liabilities:               
Tenant receivables   (2,577)   (3,511)   (4,572)
Other assets   (1,123)   (5,229)   (5,873)
Accounts payable and accrued expenses   2,880    3,949    5,021 
Tenant security deposits and other liabilities   5,079    4,619    546 
Net cash provided by operating activities   104,842    69,695    43,791 
Investing activities               
Purchase of real estate   (706,970)   (197,388)   (172,773)
Proceeds from sales of real estate, net   2,277    15,549    31,933 
Capital improvements   (14,997)   (12,003)   (13,558)
Development projects   (43,083)   (18,738)   (28,067)
Loan receivables received from others   19,642    4,086    14,632 
Loan receivables funded to others   (24,376)   (10,407)   (16,857)
Net cash used in investing activities   (767,507)   (218,901)   (184,690)

 

See accompanying notes.

 

F-14
  

 

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP

 

Consolidated Statements of Cash Flows (continued)

 

(in thousands)

 

   Year Ended December 31, 
   2014   2013   2012 
Financing activities               
Borrowings of debt  $668,000   $470,000   $267,761 
Repayment of debt   (153,157)   (488,241)   (174,127)
Payment of financing costs   (6,980)   (10,448)   (5,143)
Capital contributions   60    575    109,000 
Deferred contribution           (35,000)
Proceeds from issuance of common stock   221,720    303,600     
Cost of raising capital   (10,558)   (25,829)    
Shares issued for settlement of vested stock and exercised unit options, net   1,707         
Cash distributions to partners   (98,855)   (65,221)   (45,262)
Net cash provided by financing activities   621,937    184,436    117,229 
Net (decrease) increase in cash and cash equivalents   (40,728)   35,230    (23,670)
Cash and cash equivalents:               
Beginning of year   50,764    15,534    39,204 
End of year  $10,036   $50,764   $15,534 
Supplemental cash flow information               
Cash paid for interest  $50,972   $40,008   $46,711 
Supplemental disclosure of noncash activity               
Accrued distributions payable to partners  $   $17,694   $13,687 
Write-off of straight-line rent receivable, net  $1,549   $2,887   $1,552 
Write-off of in-place lease intangibles, net  $   $   $19 
Write-off of deferred financing costs, net  $501   $5,161   $42 
Assumed debt  $   $   $11,460 

 

See accompanying notes.

 

F-15
  

 

AVIV REIT, INC.

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP

Notes to Consolidated Financial Statements

December 31, 2014

 

1. Description of Operations and Formation

 

Aviv REIT, Inc. (AVIV or the REIT), a Maryland corporation, is the sole general partner of Aviv Healthcare Properties Limited Partnership, a Delaware limited partnership, and its subsidiaries (the Partnership). The Partnership is a majority owned subsidiary that owns all of the real estate properties. In these footnotes, the Company refers generically to AVIV, the Partnership, and their subsidiaries. The Partnership was formed in 2010 and directly or indirectly owned or leased 346 properties, principally skilled nursing facilities, across the United States at December 31, 2014. The Company is a fully integrated self-administered company that owns, acquires, develops and generates the majority of its revenues by entering into long-term triple-net leases with qualified local, regional, and national operators. In addition to the base rent, leases provide for operators to pay the Company an ongoing escrow for real estate taxes. Furthermore, all operating and maintenance costs of the buildings are the responsibility of the operators. Substantially all depreciation expense reflected in the consolidated statements of operations and comprehensive income relates to the ownership of real estate properties.

 

The Partnership is the general partner of Aviv Healthcare Properties Operating Partnership I, L.P. (the Operating Partnership), a Delaware limited partnership, and Aviv Healthcare Capital Corporation, a Delaware company. The Operating Partnership has six wholly owned subsidiaries: Aviv Financing I, L.L.C. (Aviv Financing I), a Delaware limited liability company; Aviv Financing II, L.L.C. (Aviv Financing II), a Delaware limited liability company; Aviv Financing III, L.L.C. (Aviv Financing III), a Delaware limited liability company; Aviv Financing IV, L.L.C. (Aviv Financing IV), a Delaware limited liability company; Aviv Financing V, L.L.C. (Aviv Financing V), a Delaware limited liability company; and Aviv Financing VI, L.L.C. (Aviv Financing VI) , a Delaware limited liability company.

 

All of the business, assets and operations are held by the Partnership and its subsidiaries. The REIT’s equity interest in the Partnership is linked to future investments in the REIT, such that future equity issuances by the REIT (pursuant to the Partnership’s partnership agreement) will result in a corresponding increase in the REIT’s equity interest in the Partnership. The REIT is authorized to issue 300 million shares of common stock (par value $0.01) and 25 million shares of preferred stock (par value $0.01). The REIT was funded in September 2010 with 13.2 million shares and approximately $235 million from one of the REIT’s stockholders, and approximately 8.5 million additional shares of common stock were issued by the REIT in connection with $159 million equity contributions by one of the REIT’s stockholders. The Partnership’s capital consists of partnership units, which are referred to as OP units, that are owned by AVIV and other investors.

 

On March 7, 2013, the Board of Directors and stockholders of the REIT approved an increase in the number of authorized shares of common stock to 300,000,000 shares of common stock and a 60.37-for-one split of issued and outstanding common stock. The increase in the authorized shares and the stock split became effective on March 8, 2013 when the REIT’s charter was amended for such increase in the number of authorized REIT shares and the stock split. The common share and per common share amounts in these consolidated financial statements and notes to consolidated financial statements have been retrospectively restated to reflect the 60.37-for-one split.

 

On March 26, 2013, the REIT completed an initial public offering (IPO) of its common stock pursuant to a registration statement filed with the SEC, which became effective on March 20, 2013. The Company received net proceeds after underwriting discounts and commissions, of $282.3 million, exclusive of other costs of raising capital in consideration for the issuance and sale of approximately 15.2 million shares of common stock (which included approximately 2.0 million shares sold to the underwriters upon exercise of their option to purchase additional shares to cover over-allotments) at a price to the public of $20.00 per share. In connection with the IPO, the Partnership’s Class A, B, C, D, F and G Units were converted into a single class of OP units.

 

Immediately prior to the completion of the IPO, there were outstanding approximately 21.7 million shares of common stock of the REIT, limited partnership units of the Partnership which were converted into approximately 11.9 million OP units in connection with the IPO, and 125 shares of preferred stock of the REIT. On April 15, 2013, the 125 shares of preferred stock outstanding were redeemed.

 

On April 9, 2014, the Company issued 9.2 million shares of common stock and received net proceeds of $221.7 million in a secondary underwritten public offering. At December 31, 2014, there were approximately 48.4 million shares of common stock outstanding and 10.3 million OP units outstanding which are redeemable for cash or, at the REIT’s election, for shares of common stock of the REIT. The operating results of the Partnership are allocated based upon the REIT’s and the limited partners’ respective economic interests therein. The REIT’s ownership of the Partnership was 82.5% as of December 31, 2014. The REIT’s weighted average economic ownership of the Partnership for the years ended December 31, 2014, 2013, and 2012 were 79.8%, 74.0%, and 62.5%, respectively.

 

F-16
  

 

2. Summary of Significant Accounting Policies

 

Basis of Presentation

 

This report combines the Annual Reports on Form 10-K for the year ended December 31, 2014 of AVIV and the Partnership. AVIV is a real estate investment trust and the general partner of the Partnership. Unless the context requires otherwise or except as otherwise noted, as used herein the words “we,” the “Company,” “us” and “our” refer to AVIV and AVIV’s controlled subsidiaries and the Partnership and the Partnership’s controlled subsidiaries collectively, as the operations of the two aforementioned entities are materially comparable for the periods presented.

 

AVIV is a real estate investment trust, or REIT, and the general partner of the Partnership. The Partnership’s capital is comprised of units of beneficial interest, or OP units. As of December 31, 2014, AVIV owned 82.5% of the economic interest in the Partnership, with the remaining interest being owned by investors. Investors may redeem their OP units for cash or, at the election of AVIV, for shares of AVIV’s common stock, on a one-for-one basis. As the sole general partner of the Partnership, AVIV has exclusive control of the Partnership’s day-to-day management.

 

The Company believes combining the Annual Reports on Form 10-K of AVIV and the Partnership into this single report provides the following benefits:

 

    enhances investors’ understanding of AVIV and the Partnership by enabling investors to view the business as a whole in the same manner as management views and operates the business;

 

    eliminates duplicative disclosure and provides a more streamlined and readable presentation since a substantial portion of the disclosure in this report applies to both AVIV and the Partnership; and

 

    creates time and cost efficiencies through the preparation of one combined report instead of two separate reports.

 

Management operates AVIV and the Partnership as one business. The management of AVIV consists of the same employees as the management of the Partnership.

 

The Company believes it is important for investors to understand the few differences between AVIV and the Partnership in the context of how AVIV and the Partnership operate as a consolidated company. AVIV is a REIT, whose only material asset is its ownership of OP units of the Partnership. As a result, AVIV does not conduct business itself, other than acting as the sole general partner of the Partnership, issuing public equity from time to time and guaranteeing unsecured debt of the Partnership. AVIV has not issued any indebtedness, but has guaranteed all of the unsecured debt of the Partnership. The Partnership indirectly holds all the real estate assets of the Company. Except for net proceeds from public equity issuances by AVIV, which are contributed to the Partnership in exchange for OP units, the Partnership generates all remaining capital required by the Company’s business. These sources include the Partnership’s operations, its direct or indirect incurrence of indebtedness, and the issuance of OP units.

 

As general partner with control of the Partnership, AVIV consolidates the Partnership for financial reporting purposes. The presentation of stockholders’ equity and partners’ capital are the main areas of difference between the consolidated financial statements of AVIV and those of the Partnership. AVIV’s stockholders’ equity is comprised of common stock, additional paid in capital and retained earnings (accumulated deficit). The Partnership’s capital is comprised of OP units that are owned by AVIV and the other partners. The OP units held by the limited partners (other than AVIV) in the Partnership are presented as part of partners’ capital in the Partnership’s consolidated financial statements and as “noncontrolling interests-operating partnership” in AVIV’s consolidated financial statements. There is no difference between the assets and liabilities of AVIV and the Partnership as of December 31, 2014. Net income is the same for AVIV and the Partnership.

 

In order to highlight the few differences between AVIV and the Partnership, there are sections in this report that discuss AVIV and the Partnership separately, including separate financial statements and controls and procedures sections. In the sections that combine disclosure for AVIV and the Partnership, this report refers to actions or holdings as being actions or holdings of the Company. Although the Partnership is generally the entity that enters into contracts, holds assets and issues debt, we believe that reference to the Company in this context is appropriate because the business is one enterprise and the Company operates the business through the Partnership.

 

The accompanying consolidated financial statements have been prepared by management in accordance with U.S. generally accepted accounting principles, or GAAP. All significant intercompany accounts and transactions have been eliminated in the consolidated financial statements. Certain prior period amounts have been reclassified with no effect on the Company’s consolidated financial position or results of operations.

 

The Company manages its business as a single business segment as defined in Accounting Standards Codification (ASC) 280, Segment Reporting. The Company has one reportable segment consisting of investments in healthcare properties, consisting primarily

 

F-17
  

 

of skilled nursing facilities, or SNFs, assisted living facilities, or ALFs, and other healthcare properties located in the United States. All of the Company’s properties generate similar types of revenues and expenses related to tenant rent and reimbursements and operating expenses.

 

Estimates

 

The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Cash and Cash Equivalents

 

Cash and cash equivalents consist of cash and highly liquid short-term investments with original maturities of three months or less. The Company maintains cash and cash equivalents in United States banking institutions that exceed amounts insured by the Federal Deposit Insurance Corporation. The Company believes the risk of loss from exceeding this insured level is minimal.

 

Real Estate Investments

 

The Company periodically assesses the carrying value of real estate investments and related intangible assets in accordance with ASC 360, Property, Plant, and Equipment (ASC 360), to determine if facts and circumstances exist that would suggest that assets might be impaired or that the useful lives should be modified. In the event impairment in value occurs and a portion of the carrying amount of the real estate investments will not be recovered in part or in whole, a provision will be recorded to reduce the carrying basis of the real estate investments and related intangibles to their estimated fair value. The estimated fair value of the Company’s rental properties is determined by using customary industry standard methods that include discounted cash flow and/or direct capitalization analysis (Level 3) or estimated cash proceeds received upon the anticipated disposition of the asset from market comparables (Level 2). As part of the impairment evaluation, the buildings in the following locations were impaired to reflect the estimated fair values (Level 2).

 

   For the Years Ended December 31, 
   2014   2013   2012 
       (in thousands)     
Medford, MA (1)  $   $   $ 
Zion, IL           1,000 
Bremerton, WA           150 
Youngtown, AZ           1,635 
Fall River, MA           141 
Cincinnati, OH           90 
West Chester, OH           3,414 
Columbus, TX           1,422 
Benton Harbor, MI           491 
Omaha, NE           742 
Searcy, AR       500    1,898 
Cathlamet, WA           93 
Methuen, MA           41 
Willmar, MN   862         
Jasper, TX   1,479         
   $2,341   $500   $11,117 

 

(1) Included in discontinued operations and other expenses

 

Buildings and building improvements are recorded at cost and have been assigned useful lives up to 40-years and are depreciated on the straight-line method. Personal property, furniture, and equipment have been assigned estimated useful lives up to 10 years and are depreciated on the straight-line method.

 

The Company may advance monies to its lessees for the purchase, generally, of furniture, fixtures, or equipment or other purposes. Required minimum lease payments due from the lessee increase to provide for the repayment of such amounts over a stated term. These advances in the instance where the depreciable life of the newly purchased asset is less than the remaining lease term are reflected as loan receivables on the consolidated balance sheets, and the incremental lease payments are bifurcated between principal and interest over the stated term. In the instance where the depreciable life of the newly purchased assets is longer than the remaining

 

F-18
  

 

lease term, the purchase is recorded as property when such assets are deemed to be owned by the Company. In other instances, explicit secured loans are made to lessees for working capital and other funding needs and provide for monthly principal and interest payments generally ranging from five to 10 years.

 

Purchase Accounting

 

The Company allocates the purchase price of facilities between net tangible and identified intangible assets acquired and liabilities assumed as a result of the Company purchasing the business and subsequently leasing the business to unrelated third party operators. The Company makes estimates of the fair value of the tangible and intangible assets and acquired liabilities using information obtained from multiple sources as a result of preacquisition due diligence, marketing, leasing activities of the Company’s operator base, industry surveys of critical valuation metrics such as capitalization rates, discount rates and leasing rates and appraisals (Level 3). The Company allocates the purchase price of facilities to net tangible and identified intangible assets and liabilities acquired based on their fair values in accordance with the provisions of ASC 805, Business Combinations (ASC 805). The determination of fair value involves the use of significant judgment and estimation.

 

The Company determines fair values as follows:

 

    Real estate investments are valued using discounted cash flow projections that assume certain future revenue and costs and consider capitalization and discount rates using current market conditions.

 

    The Company allocates the purchase price of facilities to net tangible and identified intangible assets acquired and liabilities assumed based on their fair values.

 

    Other assets acquired and other liabilities assumed are valued at stated amounts, which approximate fair value.

 

    Assumed debt balances are valued at fair value, with the computed discount/premium amortized over the remaining term of the obligation.

 

The Company determines the value of land based on third party appraisals. The fair value of in-place leases, if any, reflects: (i) above and below-market leases, if any, determined by discounting the difference between the estimated current market rent and the in-place rentals, the resulting intangible asset or liability of which is amortized to rental revenue over the remaining life of the associated lease plus any fixed rate renewal periods if applicable; (ii) the estimated value of the cost to obtain operators, including operator allowances, operator improvements, and leasing commissions, which is amortized over the remaining life of the associated lease; and (iii) an estimated value of the absorption period to reflect the value of the rents and recovery costs foregone during a reasonable lease-up period as if the acquired space was vacant, which is amortized over the remaining life of the associated lease. The Company also estimates the value of operator or other customer relationships acquired by considering the nature and extent of existing business relationships with the operator, growth prospects for developing new business with such operator, such operator’s credit quality, expectations of lease renewals with such operator, and the potential for significant, additional future leasing arrangements with such operator. The Company amortizes such value, if any, over the expected term of the associated arrangements or leases, which would include the remaining lives of the related leases. The amortization is included in the consolidated statements of operations and comprehensive income in rental income (above/below-market leases) or depreciation and amortization expense (in-place lease assets). Generally, the Company’s purchase price allocation of the purchased business and subsequent leasing of the business to unrelated third party operators does not include an allocation to any intangible assets or intangible liabilities, as they are either immaterial or do not exist.

 

Revenue Recognition

 

Rental income is recognized on a straight-line basis over the term of the lease when collectability is reasonably assured. Differences between rental income earned and amounts due under the lease are charged or credited, as applicable, to straight-line rent receivable, net. Income recognized from this policy is titled straight-line rental income. Additional rents from expense reimbursements for insurance, real estate taxes and certain other expenses are recognized in the period in which the related expenses are incurred and the net impact is reflected in rental income on the consolidated statements of operations and comprehensive income.

 

Below is a summary of the components of rental income for the years ended December 31, 2014, 2013 and 2012 (in thousands):

 

   2014   2013   2012 
Cash rental income  $172,493   $130,666   $112,068 
Straight-line rental income, net   4,788    4,478    7,656 
Rental income from intangible amortization , net   666    1,369    1,486 
Total rental income  $177,947   $136,513   $121,210 

 

During the years ended December 31, 2014, 2013, and 2012 straight-line rental income (loss) includes a write-off (expense) of straight-line rent receivable, net of approximately $1.5 million, $2.9 million, and $1.5 million, respectively, due to the early termination of leases and replacement of operators.

 

F-19
  

 

The Company’s reserve for uncollectible operator receivables is included as a component of reserve for uncollectible loan and other receivables in the consolidated statements of operations and comprehensive income. The amount incurred during the years ended December 31, 2014, 2013, and 2012 was $0.1 million, $0.1 million, and $10.3 million, respectively.

 

Lease Accounting

 

The Company, as lessor, makes a determination with respect to each of its leases whether they should be accounted for as operating leases or direct financing leases. The classification criteria is based on estimates regarding the fair value of the leased facilities, minimum lease payments, effective cost of funds, the economic life of the facilities, the existence of a bargain purchase option, and certain other terms in the lease agreements. Payments received under operating leases are accounted for in the statements of operations and comprehensive income as rental income for actual rent collected plus or minus a straight-line adjustment for minimum lease escalators. Assets subject to operating leases are reported as real estate investments in the consolidated balance sheets. For facilities leased as direct financing arrangements, an asset equal to the Company’s net initial investment is established on the balance sheet titled assets under direct financing leases. Payments received under the financing lease are bifurcated between interest income and principal amortization to achieve a consistent yield over the stated lease term using the interest method. Principal amortization (accretion) is reflected as an adjustment to the asset subject to a financing lease.

 

All of the Company’s leases contain fixed or formula-based rent escalators. To the extent that the escalator increases are tied to a fixed index or rate, lease payments are accounted for on a straight-line basis over the life of the lease.

 

Deferred Finance Costs

 

Deferred finance costs are being amortized using the straight-line method, which approximates the interest method, over the term of the respective underlying debt agreement.

 

Loan Receivables

 

Loan receivables consist of mortgage loans, capital improvement loans and working capital loans to operators. Mortgage loans represent the financing provided by the Company to operators or owners that are secured by mortgages on real property. Capital improvement loans represent the financing provided by the Company to perform certain capital improvements and/or to acquire furniture, fixtures, and equipment while the operator is operating the facility. Working capital loans to operators represent financing provided by the Company to operators for working capital needs that are secured with non-mortgage collateral or that are unsecured. Loan receivables are carried at their principal amount outstanding. Management periodically evaluates outstanding loans and notes receivable for collectability on a loan-by-loan basis. When management identifies potential loan impairment indicators, such as nonpayment under the loan documents, impairment of the underlying collateral, financial difficulty of the operator, or other circumstances that may impair full execution of the loan documents, and management believes it is probable that all amounts will not be collected under the contractual terms of the loan, the loan is written down to the present value of the expected future cash flows. Loan impairment is monitored via a quantitative and qualitative analysis including credit quality indicators and it is reasonably possible that a change in estimate could occur in the near term. As of December 31, 2014 and 2013, respectively, loan receivable reserves amounted to approximately $3.4 million and $0 million, respectively. No other circumstances exist that would suggest that additional reserves are necessary at the balance sheet dates other than as disclosed in Footnote 5.

 

Stock-Based Compensation

 

The Company follows ASC 718—Stock Compensation (“ASC 718”) in accounting for its share-based payments. This guidance requires measurement of the cost of employee services received in exchange for stock compensation based on the grant-date fair value of the employee stock awards. This cost is recognized as compensation expense ratably over the employee’s requisite service period. Incremental compensation costs arising from subsequent modifications of awards after the grant date must be recognized when incurred. Additionally, the Company must make estimates regarding employee forfeitures in determining compensation expense. Subsequent changes in actual experience are monitored and estimates are updated as information is available. The non-cash stock-based compensation expense incurred by the Company through December 31, 2014 is summarized in Footnote 15.

 

Fair Value of Financial Instruments

 

ASC 820, Fair Value Measurements and Disclosures (ASC 820), establishes a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels are defined as follows:

 

    Level 1—Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets;

 

F-20
  

 

    Level 2—Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument; and

 

    Level 3—Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

 

The Company’s interest rate swaps were valued using models developed by the respective counterparty that use as their basis readily observable market parameters and are classified within Level 2 of the valuation hierarchy. As of December 31, 2014, the Company has no outstanding swaps.

 

Cash and cash equivalents and derivative financial instruments are reflected in the accompanying consolidated balance sheets at amounts considered by management to reasonably approximate fair value. Management estimates the fair value of its long-term debt using a discounted cash flow analysis based upon the Company’s current borrowing rate for debt with similar maturities and collateral securing the indebtedness. The Company had outstanding secured loans, unsecured notes payable, and a line of credit with a carrying value of approximately $1.2 billion and $686.4 million as of December 31, 2014 and 2013, respectively. The fair values of debt as of December 31, 2014 and 2013 were $1.2 billion and $705.8 million, respectively, based upon interest rates available to the Company on similar borrowings (Level 3). Management estimates the fair value of its loan receivables using a discounted cash flow analysis based upon the Company’s current interest rates for loan receivables with similar maturities and collateral securing the indebtedness. The Company had outstanding loan receivables with a carrying value of approximately $42.7 million and $41.7 million as of December 31, 2014 and 2013, respectively. The fair values of loan receivables as of December 31, 2014 and 2013 approximate their carrying value based upon interest rates available to the Company on similar borrowings.

 

Derivative Instruments

 

In the normal course of business, a variety of financial instrument are used to manage or hedge interest rate risk. The Company has implemented ASC 815, Derivatives and Hedging (ASC 815), which establishes accounting and reporting standards requiring that all derivatives, including certain derivative instruments embedded in other contracts, be recorded as either an asset or liability measured at their fair value unless they qualify for a normal purchase or normal sales exception. When specific hedge accounting criteria are not met, ASC 815 requires that changes in a derivative’s fair value be recognized currently in earnings. Changes in the fair market values of the Company’s derivative instruments are recorded in the consolidated statements of operations and comprehensive income if the derivative does not qualify for or the Company does not elect to apply hedge accounting. If the derivative is deemed to be eligible for hedge accounting, such changes are reported in accumulated other comprehensive income within the consolidated statement of changes in equity, exclusive of ineffectiveness amounts, which are recognized as adjustments to net income. All of the changes in the fair market values of our derivative instruments are recorded in the consolidated statements of operations and comprehensive income for our interest rate swaps that were terminated in September 2010. In November 2010, the Company entered into two interest rate swaps (which were settled at the IPO) and account for changes in fair value of such hedges through accumulated other comprehensive (loss) income in equity in our financial statements via hedge accounting. Derivative contracts are not entered into for trading or speculative purposes. Furthermore, the Company has a policy of only entering into contracts with major financial institutions based upon their credit rating and other factors. Under certain circumstances, the Company may be required to replace a counterparty in the event that the counterparty does not maintain a specified credit rating. As of December 31, 2014 and 2013, the Company has no outstanding derivative instruments.

 

Income Taxes

 

For federal income tax purposes, the Company elected, with the filing of its initial Form 1120 REIT, U.S. Income Tax Return for U.S. Real Estate Investment Trusts, to be taxed as a Real Estate Investment Trust (REIT) effective as of September 2010. To qualify as a REIT, the Company must meet certain organizational, income, asset and distribution tests. The Company currently is in compliance with these requirements and intends to maintain REIT status. If the Company fails to qualify as a REIT in any taxable year, the Company will be subject to federal income taxes at regular corporate rates (including any applicable alternative minimum tax) and may not elect REIT status for four subsequent years. However, the Company may still be subject to federal excise tax. In addition, the Company may be subject to certain state and local income and franchise taxes. Historically, the Company and its predecessor have generally only incurred certain state and local income and franchise taxes, but these amounts were immaterial in each of the periods presented. Prior to September 2010, the Partnership was a limited partnership and the consolidated operating results were included in the income tax returns of the individual partners. No uncertain income tax positions exist as of December 31, 2014 and 2013, respectively.

 

Noncontrolling Interests—Operating Partnership / Partnership Units

 

Noncontrolling interests—operating partnership, as presented on AVIV’s consolidated balance sheets, represent OP units held by individuals and entities other than AVIV.

 

F-21
  

 

Noncontrolling interests—operating partnership, which can be settled by issuance of unregistered shares, are reported in the equity section of the consolidated balance sheets of AVIV. They are adjusted for income, losses and distributions allocated to OP units not held by AVIV. Adjustments to noncontrolling interests – operating partnership are recorded to reflect increases or decreases in the ownership of the Partnership by holders of OP units as a result of the redemptions of OP units for cash or in exchange for shares of AVIV’s common stock.

 

Prior to the IPO, the capital structure of our operating partnership consisted of six classes of partnership units, each of which had different capital accounts and each of which was entitled to different distributions. In connection with the IPO, each class of units of the Partnership was converted into an aggregate of 11,938,420 OP units held by limited partners of the Partnership. As of December 31, 2014, there were 10,272,374 of OP units outstanding.

 

Earnings Per Share of the REIT

 

Basic earnings per share is calculated by dividing the net income allocable to common shares for the period by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated by dividing the net income for the period by the weighted average number of common and dilutive securities outstanding during the period.

 

Earnings Per Unit of the Partnership

 

Basic earnings per unit is calculated by dividing the net income allocable to units for the period by the weighted average number of OP units outstanding during the period. Diluted earnings per unit is calculated by dividing the net income allocable to OP units for the period by the weighted average number of units and dilutive securities outstanding during the period.

 

Risks and Uncertainties

 

The Company is subject to certain risks and uncertainties affecting the healthcare industry as a result of healthcare legislation and continuing regulation by federal, state, and local governments. Additionally, the Company is subject to risks and uncertainties as a result of changes affecting operators of nursing home facilities due to the actions of governmental agencies and insurers to limit the growth in cost of healthcare services.

 

Discontinued Operations

 

In accordance with ASC 205-20, Presentation of Financial Statements-Discontinued Operations (ASC 205-20), the results of operations related to the actual or planned disposition of rental properties are reflected in the consolidated statements of operations and comprehensive income as discontinued operations for all periods presented prior to the Company’s adoption of ASU No. 2014-08 on January 1, 2014.

 

Recent Accounting Pronouncements

 

In April 2014, the FASB issued ASU No. 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (ASU No. 2014-08). ASU No. 2014-08 changes the definition of a discontinued operation to include only those disposals of components of an entity that represent a strategic shift that has (or will have) a major effect on an entity’s operations and financial results. ASU No. 2014-08 is effective prospectively for fiscal years beginning after December 15, 2014 and is available for early adoption as of January 1, 2014. The Company adopted the provisions of ASU No. 2014-08 as of January 1, 2014 and incorporated the provisions of this update to its consolidated financial statements upon adoption. The adoption of ASU No. 2014-08 did not have a material impact on the Company’s financial condition or results of operations.

 

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, which creates a new topic, Accounting Standards Codification Topic 606 (Topic 606). The standard is principle-based and provides a five-step model to determine when and how revenue is recognized. The core principle is that a company should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This standard is effective for interim or annual periods beginning after December 15, 2016 and allows for either full retrospective or modified retrospective adoption. Early adoption of this standard is not allowed. The Company is currently evaluating the impact the adoption of Topic 606 will have on its consolidated financial statements.

 

In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements - Going Concern. This update provide guidance about management’s responsibilities to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures in certain circumstances. An entity’s management, in connection with the preparation of financial statements, to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued. Management’s evaluation should be based on relevant conditions and events that are known or reasonably knowable at the date the financial statements are issued. When management identifies conditions or events that raise

 

F-22
  

 

substantial doubt about an entity’s ability to continue as a going concern, the entity should disclose information that enables users of the financial statements to understand all of the following: (1) principal conditions or events that raised substantial doubt about the entity’s ability to continue as a going concern (before consideration of management’s plans); (2) management’s evaluation of the significance of those conditions or events in relation to the entity’s ability to meet its obligations; and (3) management’s plans that alleviated substantial doubt about the entity’s ability to continue as a going concern or management’s plans that are intended to mitigate the conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern. ASU No. 2014-15 is effective for interim and annual reporting periods after December 15, 2016 and early application is permitted. The Company is currently assessing this guidance for future implementation.

 

3. Omega Merger

 

On October 31, 2014, AVIV announced that our Board of Directors had unanimously approved a definitive merger agreement with Omega Healthcare Investors, Inc. (NYSE: OHI) (Omega) pursuant to which Omega will acquire all of the outstanding shares of AVIV in a stock-for-stock merger. Under the terms of the agreement, AVIV shareholders will receive a fixed exchange ratio of 0.90 Omega shares for each share of AVIV common stock they own.

 

Completion of the transaction is subject to satisfaction of customary closing conditions, including the approval of stockholders of both companies. The transaction is currently expected to close in the first half of 2015.

 

On February 2, 2015, AVIV announced that it has set the date of its special meeting of stockholders to consider and vote on, among other things, a proposal to approve its previously announced merger with Omega. The special meeting will be held on Friday, March 27, 2015. AVIV stockholders of record as of the close of business on February 12, 2015 will be entitled to receive notice of and to participate at the special meeting.

 

Additional information about the proposed merger transaction and the special meeting of stockholders to consider and vote on, among other things, a proposal to approve the proposed merger transaction, is included in the preliminary joint proxy statement/prospectus filed by Omega with the Securities and Exchange Commission (the SEC) on January 5, 2015, as amended on February 17, 2015 and the definitive joint proxy statement/prospectus which was mailed to stockholders of record after the related registration statement was declared effective by the SEC.

 

4. Real Estate Assets

 

The Company had the following acquisitions during the years ended December 31, 2014, 2013 and 2012 as described below:

 

2014 Acquisitions

 

Month Acquired

  Property Type  Location  Purchase Price
(in thousands)
 
January  SNF/ALF/ILF  MN  $40,000 
January  SNF  TX   15,920 
March  SNF  IA   13,500 
March  SNF  KY   35,000 
April  SNF  FL   6,000 
April  SNF  TX   53,700 
May  SNF  TX   3,600 
May  SNF  CA   13,350 
June  SNF  KY   6,000 
July  SNF  MO   16,200 
July  SNF  MA   32,000 
July  SNF/ALF  MA   50,000 
September  SNF/ALF  WA/ID   83,600 
October  SNF  KY   4,600 
October  SNF  TX   28,500 
December  SNF/ALF/ILF/MOB  OH/MI/NC/IN/VA   305,000 
          706,970 
February  Land Held for Development  TX   2,110 
July  Land Held for Development  MA   12,288 
October  Land Held for Development  OH   1,250 
December  Land Held for Development  OH   750 
         $723,368 

 

F-23
  

 

2013 Acquisitions

 

Month Acquired

  Property Type  Location  Purchase Price (in
thousands)
 
April  Traumatic Brain Injury  CA  $779 
April  Traumatic Brain Injury  CA   697 
April  SNF  TX   2,400 
April  Medical Office Building  IN   1,200 
May  SNF  OH   14,350 
June  SNF  OK   6,200 
August  SNF  KY   9,000 
September  SNF  TX   3,450 
October  ALF  FL   13,000 
October  SNF  OH/IN   35,900 
November  SNF  OH   41,000 
November  SNF  AR   1,162 
December  Hospital  IN   9,300 
December  SNF/ALF/Long-Term Acute Care  OH   35,600 
December  SNF  TX   13,000 
December  SNF  IL   7,000 
December  SNF  TX   3,350 
          197,388 
May  Land Parcel in Development  CT   2,400 
         $199,788 

 

2012 Acquisitions

 

Month Acquired

  Property Type  Location  Purchase Price (in
thousands)
 
January  Land Parcel  OH  $275 
March  SNF  NV   4,800 
March  SNF  OH   2,500 
March  SNF/ALF  IA/NE   16,200 
April  SNF  TX   72,700 
April  ALF  FL   4,936 
May  Land Parcel  TX   60 
May  ALF  WI   2,500 
June  ALF  CT   16,000 
July  LTAC  IN   8,400 
August  SNF  ID   6,000 
September  Traumatic Brain Injury  CA   1,162 
September  SNF  KY   9,925 
October  SNF  WI   7,600 
November  SNF  TX   5,000 
November  ALF  FL   14,100 
December  Traumatic Brain Injury  CA   975 
December  SNF  OH   7,600 
December  SNF/ALF  OK   3,500 
          184,233 
December  Land Parcel in Development  TX   93 
         $184,326 

 

F-24
  

 

On July 10, 2014, the Company acquired three properties and two land parcels in Massachusetts for a purchase price of $94.3 million. Sidney and Evelyn Insoft, the parents of Steven Insoft, the Company’s President and Chief Operating Officer, jointly hold a 50% equity interest in the sellers of the properties, representing a gross economic interest in the sale of approximately $47.1 million. The Company believes that the terms of the acquisition were fair and reasonable and reflect terms that the Company would expect to obtain in an arm’s length transaction for comparable properties.

 

The following table illustrates the effect on total revenues and net income as if the Company had consummated the acquisitions as of January 1, 2013 (in thousands, unaudited):

 

   For the Year Ended
December 31,
 
   2014   2013 
Total revenues  $231,166   $212,541 
Net income   77,881    68,362 

 

For the year ended December 31, 2014, revenues attributable to the acquired assets were approximately $24.4 million and net income attributable to the acquired assets was approximately $12.6 million recognized in the consolidated statements of operations and comprehensive income.

 

Transaction-related costs are not expected to have a continuing significant impact on our financial results and therefore have been excluded from these pro forma results. Related to the above business combinations, the Company incurred $4.8 million and $1.2 million of transaction costs for the year ended December 31, 2014 and 2013, respectively.

 

In accordance with ASC 805, the Company allocated the approximate net purchase price paid for these properties acquired as follows:

 

   2014   2013   2012 
   (in thousands) 
Land  $50,231   $21,066   $20,831 
Buildings and improvements   614,193    163,634    148,307 
Furniture, fixtures and equipment   42,039    12,688    15,188 
Construction in progress and land held for development   16,398    2,400     
Above market leases   122         
Lease intangibles   385         
Mortgages and other notes payable assumed           (11,460)
Borrowings and available cash  $723,368   $199,788   $172,866 

 

For the business combinations in 2014, 2013 and 2012, other than the acquisition in December 2014 for a purchase price of $305.0 million, the Company’s purchase price allocation of the purchased business and subsequent leasing of the business to unrelated third party operators does not include an allocation to any intangible assets or intangible liabilities, as these amounts are either immaterial or do not exist.

 

The Company considers renewals on above- or below-market leases when ascribing value to the in-place lease intangible liabilities at the date of a property acquisition. In those instances where the renewal lease rate pursuant to the terms of the lease does not adjust to a current market rent, the Company evaluates whether the stated renewal rate is above or below current market rates and considers the past and current operations of the property, the current rent coverage ratio of the operator, and the number of years until potential renewal option exercise. If renewal is considered probable based on these factors, an additional lease intangible liability is recorded at acquisition and amortized over the renewal period.

 

Dispositions

 

For the year ended December 31, 2014, the Company disposed of eight properties for a total sales price of $2.4 million, and the Company recognized a net loss on sale of approximately $2.5 million. The total sales price and net gain are net of transaction costs incurred in relation to the closings at the time of disposition.

 

F-25
  

 

For the year ended December 31, 2013, the Company disposed of six properties, one vacant land parcel and certain other assets for a total sales price of $16.3 million, and the Company recognized a net gain on sale of approximately $1.0 million. The total sales price and net gain are net of transaction costs incurred in relation to the closings at the time of disposition.

 

For the year ended December 31, 2012, the Company disposed of seven properties and one vacant land parcel for a total sales price of $36.2 million and the Company recognized a net gain on sale of approximately $4.4 million (included in discontinued operations). The total sales price and net gain are net of transaction costs incurred in relation to the closings at the time of disposition.

 

The following summarizes the Company’s construction in progress and land held for development at December 31 (in thousands):

 

   2014   2013   2012 
Beginning Balance, January 1  $23,292   $4,576   $28,293 
Additions   41,555    20,467    25,428 
Sold           (8,038)
Placed in service   (41,697)   (1,751)   (41,107)
   $23,150   $23,292   $4,576 

 

During 2014, 2013 and 2012 the Company capitalized expenditures for improvements related to various construction and reinvestment projects. In 2014, the Company placed into service eight completed investment projects at eight properties located in California, Connecticut, Pennsylvania, Texas and Indiana. In 2013, the Company placed into service one completed investment project at one property located in California. In 2012, the Company placed into service three additions and two remodels to three properties located in Washington and two development properties located in Connecticut. In accordance with ASC 835 Capitalization of Interest (ASC 835), the Company capitalizes interest based on the average cash balance of construction in progress for the period using the weighted-average interest rate on all outstanding debt, which approximated 5.1% for the year ended December 31, 2014. The balance of capitalized interest within construction in progress at December 31, 2014, 2013 and 2012 was $16,000, $0.8 million, and $0.1 million, respectively. The amount capitalized during the year ended December 31, 2014, 2013 and 2012, relative to interest incurred was $0.7 million, $0.8 million, and $1.1 million, respectively.

 

5. Loan Receivables

 

The following summarizes the Company’s loan receivables, net activity during the years ended December 31, 2014 and 2013 (in thousands):

 

   2014   2013 
   Mortgage
Loans
   Capital
Improvement
Loans
   Working
Capital
Loans
   Total
Loans
   Mortgage
Loans
   Capital
Improvement
Loans
   Working
Capital
Loans
   Total
Loans
 
Beginning balance  $28,316   $4,580   $8,790   $41,686   $16,690   $6,250   $9,699   $32,639 
New loans issued           11,893    11,893    9,520        1,069    10,589 
Existing loans funded   5,908        6,575    12,483    3,234    (83)       3,151 
Reserve for uncollectible loans           (3,406)   (3,406)                
Loan write offs                           (11)   (11)
Loan amortization and repayments   (9,846)   (1,282)   (8,831)   (19,959)   (1,128)   (1,587)   (1,967)   (4,682)
   $24,378   $3,298   $15,021   $42,697   $28,316   $4,580   $8,790   $41,686 

 

F-26
  

 

Interest income on loans and financing leases for the years ended December 31, 2014, 2013 and 2012 (in thousands):

 

   2014   2013   2012 
Mortgage loans  $1,816   $1,692   $1,104 
Capital improvement loans   465    691    1,386 
Working capital loans   730    561    704 
Direct financing lease   1,472    1,456    1,439 
   $4,483   $4,400   $4,633 

 

The Company’s reserve on a loan-by-loan basis for uncollectible loan receivables balances at December 31, 2014 and 2013 was approximately $3.4 million and $0 million, respectively and any movement in the reserve is reflected in reserve for uncollectible loan and other receivables in the consolidated statements of operations and comprehensive income. The gross balance of loan receivables for which a reserve on a loan-by-loan basis for uncollectible loan receivables has been applied was approximately $3.4 million and $0 million, at December 31, 2014 and 2013, respectively.

 

During 2014 and 2013, the Company funded loans for both working capital and capital improvement purposes to various operators. All loans held by the Company accrue interest and are recorded as interest income unless the loan is deemed impaired in accordance with Company policy. The payments received from the operator cover both interest accrued as well as amortization of the principal balance due. Any payments received from the operator made outside of the normal loan amortization schedule are considered principal prepayments and reduce the outstanding loan receivables balance.

 

6. Deferred Finance Costs

 

The following summarizes the Company’s deferred finance costs at December 31, 2014 and 2013 (in thousands):

 

   2014   2013 
Gross amount  $27,902   $21,881 
Accumulated amortization   (8,878)   (5,238)
Net  $19,024   $16,643 

 

The estimated annual amortization of the deferred finance costs for each of the five succeeding years is as follows (in thousands):

 

2015  $4,412 
2016   4,412 
2017   4,412 
2018   3,281 
2019   1,301 
Thereafter   1,206 
Total  $19,024 

 

During the year ended December 31, 2014, the Company wrote-off deferred financing costs of approximately $0.8 million with approximately $0.3 million of accumulated amortization associated with the pay downs of previous credit facilities for a net recognition as loss on extinguishment of debt of approximately $0.5 million.

 

During the year ended December 31, 2013, the Company wrote-off deferred financing costs of approximately $9.7 million with approximately $4.6 million of accumulated amortization associated with the pay downs of previous credit facilities for a net recognition as loss on extinguishment of debt of approximately $5.1 million.

 

F-27
  

 

7. Intangible Assets and Liabilities

 

The following summarizes the Company’s intangible assets and liabilities classified as part of other assets or other liabilities at December 31, 2014 and 2013, respectively (in thousands):

 

   Assets 
   2014   2013 
   Gross Amount   Accumulated
Amortization
   Net   Gross Amount   Accumulated
Amortization
   Net 
Above market leases  $5,634   $(2,926)  $2,708   $6,437   $(3,452)  $2,985 
In-place lease assets   1,037    (208)   829    652    (130)   522 
Operator relationship   212    (51)   161    212    (34)   178 
   $6,883   $(3,185)  $3,698   $7,301   $(3,616)  $3,685 

 

   Liabilities 
   2014   2013 
   Gross Amount   Accumulated
Amortization
   Net   Gross Amount   Accumulated
Amortization
   Net 
Below market leases  $12,933   $(6,435)  $6,498   $17,623   $(10,059)  $7,564 

 

Amortization expense for in-place lease assets and operator relationship was $0.1 million, $0.1 million, and $0.1 million for the years ended December 31, 2014, 2013, and 2012 and is included as a component of depreciation and amortization in the consolidated statements of operations and comprehensive income. Amortization expense for the above market leases intangible asset for the years ended December 31, 2014, 2013, and 2012 was approximately $0.4 million, $0.5 million, $0.6 million, respectively, and is included as a component of rental income in the consolidated statements of operations and comprehensive income. Accretion for the below market leases intangible liability for the years ended December 31, 2014, 2013, and 2012 was approximately $1.1 million, $1.9 million, $2.0 million, respectively, and is included as a component of rental income in the consolidated statements of operations and comprehensive income.

 

For the year ended December 31, 2014, the Company wrote-off above market leases intangible assets of approximately $0.9 million with accumulated amortization of approximately $0.9 million, and below market leases intangible liabilities of approximately $4.7 million with accumulated accretion of approximately $4.7 million, for a net recognition of $0 in rental income from intangible amortization. These write-offs were the result of fully amortized assets and fully accreted liabilities.

 

For the year ended December 31, 2013, the Company wrote-off above market leases intangible assets of approximately $0.2 million with accumulated amortization of approximately $0.2 million, and below market leases intangible liabilities of approximately $8.0 million with accumulated accretion of approximately $8.0 million, for a net recognition of $0 in rental income from intangible amortization. These write-offs were the result of fully amortized assets and fully accreted liabilities.

 

For the year ended December 31, 2012, the Company wrote-off above market leases intangible assets of approximately $0.9 million with accumulated amortization of approximately $0.7 million, and below market leases intangible liabilities of approximately $0.8 million with accumulated accretion of approximately $0.7 million, for a net recognition of approximately $19,000 gain in rental income from intangible amortization, respectively.

 

The estimated annual amortization expense of the identified intangibles for each of the five succeeding years and thereafter is as follows:

 

Year ending December 31,

  Assets   Liabilities 
2015  $695   $891 
2016   407    868 
2017   341    726 
2018   341    721 
2019   341    721 
Thereafter   1,573    2,571 
   $3,698   $6,498 

 

F-28
  

 

8. Leases

 

As of December 31, 2014, the Company’s portfolio of investments consisted of 346 healthcare facilities, located in 30 states and operated by 37 third party operators. At December 31, 2014, approximately 53.8% (measured as a percentage of total assets) were leased by five private operators: Laurel (15.6%), Maplewood (11.5%), Saber (9.3%), EmpRes (9.1%), and Fundamental (8.3%). No other operator represents more than 7.7% of our total assets. The five states in which the Company had its highest concentration of total assets were Ohio (15.5%), Texas (15.2%), California (8.8%), Michigan (6.3%), and Connecticut (5.8%), at December 31, 2014.

 

For the year ended December 31, 2014, the Company’s rental income from operations totaled approximately $177.9 million, of which approximately $22.7 million was from Daybreak Healthcare (12.8%), $21.8 million from Saber Health Group (12.3%), and $14.9 million from EmpRes (8.4%). No other operator generated more than 8.0% of the Company’s rental income from operations for the year ended December 31, 2014.

 

The Company’s real estate investments are leased under noncancelable triple-net operating leases. Under the provisions of the leases, the Company receives fixed minimum monthly rentals, generally with annual increases, and the operators are responsible for the payment of all operating expenses, including repairs and maintenance, insurance, and real estate taxes of the property throughout the term of the leases.

 

At December 31, 2014, future minimum annual rentals to be received under the noncancelable lease terms are as follows (in thousands):

 

2015  $220,134 
2016   222,386 
2017   222,473 
2018   215,592 
2019   204,341 
Thereafter   976,513 
   $2,061,439 

 

9. Debt

 

The Company’s secured loans, unsecured notes payable and line of credit consisted of the following (in thousands):

 

   December 31,
2014
   December 31,
2013
 
HUD loan (interest rate of 5.00% on December 31, 2014 and 2013), inclusive of a $2.3 and $2.4 million premium balance at December 31, 2014 and 2013, respectively)  $13,418   $13,654 
2019 Notes (interest rate of 7.75% on December 31, 2014 and 2013), inclusive of $2.3 and $2.8 million net premium balance, respectively   402,292    402,752 
2021 Notes (interest rate of 6.00% on December 31, 2014 and 2013)   250,000    250,000 
Credit Facility (interest rate of 1.96% on December 31, 2014)   355,000     
Revolving Credit Facility (interest rate of 2.52% on December 31, 2013)       20,000 
Term Loan (interest rate of 4.00% on December 31, 2014)   180,000     
Total  $1,200,710   $686,406 

 

F-29
  

 

In conjunction with the IPO on March 26, 2013, the Company under Aviv Financing I repaid the outstanding balance of a term loan and an acquisition credit line and under Aviv Financing V repaid the outstanding balance of a 2016 revolver in the amounts of $191.2 million, $18.9 million, and $94.4 million, respectively. The Company paid $2.2 million in prepayment penalties which is included in loss on extinguishment of debt on the consolidated statements of operations and comprehensive income for the year ended December 31, 2013.

 

2019 Notes

 

On February 4, 2011, April 5, 2011, and March 28, 2012 Aviv Healthcare Properties Limited Partnership and Aviv Healthcare Capital Corporation (the Issuers) issued $200 million, $100 million and $100 million of 7 3/4% Senior Notes due in 2019 (the 2019 Notes), respectively. The REIT is a guarantor of the Issuers’ 2019 Notes. The 2019 Notes are unsecured senior obligations of the Issuers and will mature on February 15, 2019, and bear interest at a rate of 7.75% per annum, payable semiannually to holders of record at the close of business on the February 1 or the August 1 immediately preceding the interest payment date on February 15 and August 15 of each year, commencing August 15, 2011. A premium of approximately $2.75 million and $1.0 million was associated with the offering of the $100 million of 2019 Notes on April 5, 2011 and the $100 million of 2019 Notes on March 28, 2012, respectively. The premium will be amortized as an adjustment to the yield on the 2019 Notes over their term. The Company used the proceeds, amongst other things, to pay down the outstanding balance of previous credit facilities during 2012.

 

2021 Notes

 

On October 16, 2013, the Issuers issued $250 million of 6% Senior Notes due in 2021 (2021 Notes). The REIT is a guarantor of the Issuers’ 2021 Notes. The 2021 Notes are unsecured senior obligations of the Issuers and will mature on October 16, 2021, and bear interest at a rate of 6.00% per annum, payable semiannually to holders of record at the close of business on the April 1 or the October 1 immediately preceding the interest payment date on April 15 and October 15 of each year, commencing April 15, 2014. The Company used the net proceeds, amongst other things, to pay down approximately $135.0 million of the outstanding indebtedness under the Revolving Credit Facility during 2013.

 

Credit Facility

 

On March 26, 2013, the Company, through Aviv Financing IV, entered into a $300 million secured revolving credit facility and $100 million term loan with Bank of America, N.A. (collectively, the Revolving Credit Facility). On April 16, 2013, the Company converted the entire $100 million term loan into a secured revolving credit facility, thereby terminating the term loan and any availability thereunder and increasing the amount available under the secured revolving credit facility from $300 million to $400 million. On each payment date, the Company paid interest only in arrears on any outstanding principal balance. The interest rate was based on LIBOR plus a margin of 235 basis points to 300 basis points depending on the Company’s leverage ratio. Additionally, an unused fee equal to 50 basis points per annum of the daily unused balance on the Revolving Credit Facility was payable quarterly in arrears.

 

On May 14, 2014, the Company terminated the Revolving Credit Facility and, through the Partnership, entered into a new $600 million unsecured revolving credit facility (the Credit Facility). The Credit Facility has an interest rate that ranges from 170 to 225 basis points over LIBOR depending on the Company’s consolidated leverage and a maturity date of May 14, 2018. The Credit Facility can be extended for an additional year at the Company’s option, subject to the satisfaction of certain conditions, and contains an accordion feature increasing the borrowing capacity to $800 million. As of December 31, 2014, the Credit Facility had a balance of $355.0 million.

 

Term Loan

 

On December 17, 2014, the Company, through Aviv Financing VI, entered into a $180 million secured term loan (Term Loan) with General Electric Capital Corporation. On each payment date, the Company pays interest only in arrears on any outstanding principal balance until February 1, 2017 when principal and interest will be paid in arrears based on a thirty year amortization schedule. The interest rate is based on LIBOR, with a floor of 50 basis points, plus a margin of 350 basis points. The interest rate at December 31, 2014 was 4.00%. The initial term expires in December 2019 with the full balance of the loan due at that time.

 

Other Loans

 

On June 15, 2012, a subsidiary of Aviv Financing III assumed a HUD loan with a balance of approximately $11.5 million. Interest is at a fixed rate of 5.00%. The loan originated in November 2009 with a maturity date of October 1, 2044, and is based on a 35-year amortization schedule. The Company is obligated to pay the remaining principal and interest payments of the loan. A premium of $2.5 million was associated with the assumption of debt and will be amortized as an adjustment to interest expense on the HUD loan over its term.

 

F-30
  

 

 

Future annual maturities of all debt obligations for five fiscal years subsequent to December 31, 2014 and thereafter, are as follows (in thousands):

 

2015  $165 
2016   174 
2017   2,204 
2018   357,527 
2019   575,846 
Thereafter   260,165 
    1,196,081 
Debt premiums   4,629 
   $1,200,710 

 

10. Related Party Receivables and Payables

 

Related party receivables and payables represent amounts due from/to various affiliates of the Company. An officer of the Company funded approximately $2.0 million at December 31, 2012 in connection with the distribution settlement (see Footnote 12). There are no related party receivables or payables as of December 31, 2014 and 2013.

 

11. Derivatives

 

During the periods presented, the Company was party to two interest rate swaps, with identical terms of $100.0 million each, which were purchased to fix the variable interest rate on the denoted notional amount under the Term Loan. On March 26, 2013, in connection with the pay down of the Term Loan, the Company settled all interest rate swaps at a fair value of $3.6 million and such amount previously recorded in accumulated other comprehensive income (loss) was recorded within loss on extinguishment of debt in the consolidated statements of operations and comprehensive income. The interest rate swaps qualified for hedge accounting and as such the amounts previously recorded in accumulated other comprehensive income in the consolidated statement of changes in equity were reversed. For presentational purposes they are shown as one derivative due to the identical nature of their economic terms.

 

The derivative positions were valued using models developed by the respective counterparty that used as their basis readily observable market parameters (such as forward yield curves) and were classified within Level 2 of the valuation hierarchy. The Company considered its own credit risk as well as the credit risk of its counterparties when evaluating the fair value of its derivatives. As of December 31, 2014 and 2013, there are no derivative instruments outstanding.

 

12. Commitments and Contingencies

 

The Company has contractual arrangements with three operators in six of its facilities to reimburse any liabilities, obligations or claims of any kind or nature resulting from the actions of the former operators in such facilities. The Company is obligated to reimburse the fees to the operator if and when the operator incurs such expenses associated with certain Indemnified Events, as defined therein. The total possible obligation for these fees is estimated to be $2.7 million, of which approximately $2.2 million has been paid to date. The remaining $0.5 million is accrued as of December 31, 2014 as a component of other liabilities in the consolidated balance sheets.

 

The Company has purchase options with one of its tenants that are not exercisable by the tenant until January 1, 2017 for five properties, January 1, 2019 for four properties, and January 1, 2022 for five properties. If the 2017 option is not exercised, the tenant loses the right to exercise the 2019 option and the 2022 option. If the 2017 option is exercised, but the 2019 option is not exercised, the tenant loses the right to exercise the 2022 option. The purchase options call for the purchase price, as defined, to be determined at a future date. In addition, the Company has purchase options with four tenants on five properties that are exercisable by the applicable tenant at various times during the terms of the respective leases. Two of these options are exercisable at a predetermined purchase price and the remaining three call for a purchase price to be determined at a future date.

 

As of the date of this filing, four putative class actions have been filed by purported stockholders of AVIV against AVIV, its directors, Omega and Omega’s merger sub challenging the merger of AVIV and Omega in the Circuit Court of Maryland, Baltimore County. The class actions were filed on November 10, 2014, November 17, 2014, November 24, 2014, and December 2, 2014. Each plaintiff filed an amended complaint on January 22, 2015. The lawsuits seek injunctive relief preventing the parties from consummating the merger, rescission of the transactions contemplated by the merger agreement, imposition of a constructive trust in favor of the class upon any benefits improperly received by the defendants, compensatory damages, and litigation costs including attorneys’ fees. The four lawsuits were consolidated on January 28, 2015 under the title In Re Aviv REIT Inc. Stockholder Litigation, Case No. 24-C-14-006352.

 

F-31
  

  

In addition, AVIV’s Board of Directors has received a stockholder litigation demand letter dated November 17, 2014, from a law firm representing Gary Danley, who is the named plaintiff in the putative class action filed on November 24, 2014 in Circuit Court of Maryland, Baltimore County. The letter alleges that the directors of AVIV violated fiduciary duties to AVIV, and demands that the AVIV Board of Directors take action to ensure that the consideration provided in the merger is fair to AVIV and its stockholders and otherwise seek appropriate remedies for AVIV.

 

The Company’s management believes that these actions have no merit and intends to defend vigorously against them.

 

The Company is involved in various unresolved legal actions and proceedings, which arise in the normal course of our business. Although the outcome of a particular proceeding can never be predicted, we do not believe that the result of any of these other matters will have a material adverse effect on our business, operating results, liquidity or financial position.

 

13. Noncontrolling Interests – Operating Partnership / Partnership Units

 

Noncontrolling interests – operating partnership, as presented on AVIV’s consolidated balance sheets, represent the OP units held by individuals and entities other than AVIV. Accordingly, the following discussion related to noncontrolling interests – operating partnership of the REIT refers equally to OP units of the Partnership.

 

Holders of OP units are entitled to receive distributions in a per unit amount equal to the per share dividends made with respect to each share of AVIV’s common stock, if and when AVIV’s Board of Directors declares such a dividend. Holders of OP units have the right to tender their units for redemption, in an amount equal to the fair market value of AVIV’s common stock. AVIV may elect to redeem tendered OP units for cash or for shares of AVIV’s common stock. During the year ended December 31, 2014, OP unitholders redeemed a total of 1,343,908 OP units in exchange for an equal number of shares of common stock of AVIV.

 

14. Stockholders’ Equity of the REIT and Partners’ Capital of the Partnership

 

Distributions accrued are summarized as follows for the years ended December 31 (in thousands):

 

   Class A   Class B   Class C   Class D   Class F   Limited
Partner
OP Units
   REIT
Shares
 
2014  $   $   $   $   $   $16,072   $65,089 
2013  $2,797   $97   $146   $   $554   $13,064   $60,276 
2012  $9,002   $1,879   $2,541   $   $2,215   $   $27,955 

 

In connection with the IPO, Class A through F Units were converted into OP units and are no longer outstanding as of December 31, 2014. The weighted-average Units outstanding are summarized as follows for the years ended December 31:

 

   Class A   Class B   Class C   Class D   Class F   Limited
Partner
OP Units
   REIT Shares 
2014                       11,328,049    44,629,901 
2013   3,136,203    1,053,335        1,875    625,251    9,091,974    33,700,834 
2012   13,467,223    4,523,145    2    8,050    2,684,900        20,006,538 

 

In connection with the IPO each class of limited partnership units of the Partnership were converted into an aggregate of 21,653,813 OP units held by the REIT and 11,938,420 OP units held by limited partners of the Partnership. As a result, the Partnership has a single class of OP units as of March 26, 2013. As noted above, the OP units held by limited partners of the Partnership are redeemable for cash or, at the REIT’s election, unregistered shares of the REIT’s common stock on a one-for-one basis.

 

During the years ended December 31, 2014, 2013 and 2012:

 

    AVIV issued an aggregate of 16,618, 70,500, and 0 shares of common stock in connection with the Company’s annual grant of unrestricted and restricted stock to its Board of Directors, respectively;

 

    AVIV reserved for issuance an aggregate of 164,973, 226,585, and 0 shares of common stock in connection with the Company’s annual grant of restricted stock to employees, the hiring of new employees and grants and retainers for its Board of Directors, respectively. During the year ended December 31, 2014, 143,388 shares reserved for restricted stock

 

F-32
  

  

  were vested. This includes a vesting of 200% of the performance based awards and 9,947 dividend equivalents earned on these awards along with 26,724 (including dividend equivalents earned on the awards) shares reserved for restricted stock were forfeited;

 

    AVIV issued 15,180,000 shares in connection with the IPO on March 26, 2013 that resulted in proceeds to the Company, net of underwriting discounts, commissions, advisory fees and other offering costs of $282.3 million;

 

    AVIV also issued 9,200,000 shares in connection with a public offering on April 10, 2014 that resulted in proceeds to the Company, net of underwriting discounts, commissions, advisory fees and other offering costs of $211.3 million;

 

    OP unitholders redeemed a total of 1,343,908, 322,137, and 0 OP units in exchange for an equal number of shares of AVIV’s common stock, respectively; and.

 

    AVIV issued 174,467, 0 and 0 shares of common stock in connection with an option exercise, respectively.

 

For the year ended December 31, 2014, AVIV declared and paid the following cash dividends totaling $1.44 per share on its common stock, of which the Partnership paid equivalent distributions on OP units:

 

Record
Date___

  Payment
Date
  Cash
Dividend
   Ordinary
Taxable
Dividend
(unaudited)
   Nontaxable
Return of
Capital
Distributions
(unaudited)
 
3/28/2014      4/11/2014  $0.36   $0.235   $0.125 
6/27/2014  7/11/2014   0.36    0.235    0.125 
9/26/2014  10/10/2014   0.36    0.235    0.125 
12/12/2014  12/19/2014   0.36    0.235    0.125 
      $1.44   $0.94   $0.50 

 

15. Equity Compensation Plan

 

Prior to September 2010, the Partnership had established an officer incentive program linked to its future value. Awards vest annually over a five-year period assuming continuing employment by the recipient. The awards settled on December 31, 2012 in Class C Units or, at the Company’s discretion, cash. For accounting purposes, expense recognition under the program commenced in 2008, and the related expense for the years ended December 31, 2014, 2013 and 2012 was $0, $0 and $0.4 million, respectively.

 

Class D units were periodically granted to employees of Aviv Asset Management (AAM), a subsidiary of the Operating Partnership. Part of the Class D Units are defined as performance-based awards under ASC 718 and require employment of the recipient on the date of sale, disposition, or refinancing (Liquidity Event). If the employee is no longer employed on such date, the award is forfeited. The remainder of the Class D Units were time-based awards under ASC 718 and such fair value determined on the grant date was recognized over the vesting period. On March 26, 2013, the performance component Class D Units were converted to OP units in connection with the IPO, and $0.9 million of expense was recognized.

 

Restricted Stock Grants

 

On March 26, 2013 the Company adopted the Aviv REIT, Inc. 2013 Long-Term Incentive Plan (the LTIP). The purpose of the LTIP is to attract and retain qualified persons upon who, in large measure, the Company’s sustained progress, growth and profitability depend, to motivate the participants to achieve long-term Company goals and to align the participants’ interests with those of other stockholders by providing them with a proprietary interest in the Company’s growth and performance. The Company’s executive officers, employees, consultants and non-employee directors are eligible to participate in the LTIP. Under the plan, 2,000,000 shares of the Company’s common stock are available for issuance. The shares can be issued as restricted stock awards (RSAs) or as restricted stock units (RSUs).

 

Some of these RSUs are subject to time vesting and some are subject to performance vesting. The time-based equity RSUs vest over a period of three years, subject to the employee’s continued employment with the Company. The performance-based RSUs vest on the basis of Total Shareholder Return (TSR) on the Company’s stock compared to the TSR of its peer companies, as defined. The performance based RSUs are based on the companies comprising the NAREIT Equity Index and the companies comprising the Bloomberg Healthcare REIT Index for the performance periods, as defined. The RSUs carry dividend equivalent rights and are subject to the same vesting terms as the underlying RSUs.

 

F-33
  

  

During 2014, the Company issued 16,618 common shares all of which were issued, vested, and are unrestricted. Additionally, the Company granted 164,973 RSUs. In addition, 143,388 shares vested and 26,724 were subsequently forfeited prior to the year ended December 31, 2014. The restricted shares that vested satisfied the performance metric stated and were vested at 200% of the targeted award granted in 2013. Both vested restricted stock and forfeited restricted stock included dividend equivalents earned on these awards.

 

During 2013, the Company issued 70,500 RSAs, of which 23,250 shares were issued, vested, and are unrestricted and 47,250 shares were issued and are subject to a vesting period. Additionally, the Company issued 226,585 RSUs, of which 17,470 were subsequently forfeited prior to the year ended December 31, 2013. Some of these RSUs are subject to time vesting and some are subject to performance vesting.

 

For the years ended December 31, 2014 and 2013, the Company recognized total non-cash stock-based compensation expense related to the LTIP of $4.9 million and $1.9 million, respectively.

 

Restricted stock awards vest over specified periods of time as long as the employee remains with the Company. The following table sets forth the number of unvested shares of restricted stock and the weighted average fair value of these shares at the date of grant:

 

   2014   2013 
   Shares of
Restricted Stock
   Weighted Average
Fair Value at
Date of Grant (2)
   Shares of
Restricted Stock
   Weighted Average
Fair Value at
Date of Grant (2)
 
Unvested balance at January 1   256,092   $29.93       $ 
Granted   221,583   $28.00    273,923   $30.47 
Vested (1)   (143,388)  $35.67       $ 
Forfeited   (26,724)  $30.53    (17,831)  $39.14 
Unvested balance at December 31   307,563   $25.73    256,092   $29.93 

 

(1) Includes 47,068 shares which were used to settle minimum employee withholding tax obligations for multiple employees of approximately $1.5 million in 2014. A net of 96,320 shares of common stock were delivered in the year ended December 31, 2014.

(2) The grant date fair value for the time-based awards was based on the market price of the Company’s common stock on the date of grant. The grant date fair value for the performance-based awards was based on a Monte Carlo simulation model.

 

As of December 31, 2014, total unearned compensation on restricted stock was $5.6 million, and the weighted average vesting period was 1.66 years.

 

Option Awards

 

On September 17, 2010, the Company adopted the 2010 Management Incentive Plan (the MIP), which provides for the grant of option awards. Two thirds of the options granted under the MIP were performance based awards whose criteria for vesting is tied to a future liquidity event (as defined) and also contingent upon meeting certain return thresholds (as defined). The grant date fair value associated with all performance-based award options of the Company aggregated to approximately $7.4 million at the time of the IPO. One third of the options granted under the MIP were time based awards and the service period for these options is four years with shares vesting at a rate of 25% ratably from the grant date.

 

In connection with the IPO, all options outstanding under the MIP, representing options to purchase 5,870,138 shares with a weighted average exercise price of $17.47 per share, became fully-vested. In addition, recipients were entitled to receive dividend equivalents on their options awarded under the MIP. Dividend equivalents were paid on time-based options on (i) the date of vesting, with respect to any portion of a time-based option that was unvested on the date the dividend equivalent was accrued, and (ii) the last day of the calendar quarter in which such dividends were paid to stockholders, with respect to any portion of a time-based option vested as of the date the dividend equivalent was accrued. Dividend equivalents accrued and unpaid prior to the consummation of the IPO in the approximate amount of $14.8 million were paid in shares of common stock, net of applicable withholding of approximately $6.8 million, in an amount based on the IPO price of common stock. No dividend equivalents will be paid for any MIP options with respect to periods after the date of the IPO by the Company.

 

In connection with the IPO, the holders of option awards under the MIP received a new class of units of LG Aviv L.P., the legal entity through which Lindsay Goldberg holds its interest in the REIT, equal to the number of options held by such persons immediately prior to the consummation of the IPO. Under the limited partnership agreement of LG Aviv L.P., the units are entitled to

 

F-34
  

  

receive an aggregate distribution amount equal to 14.9% of the dividend distributions declared and received by LG Aviv L.P. after the consummation of the IPO in respect of its shares of common stock. The distribution amount will be paid by LG Aviv L.P. ratably to each holder of such units on the distribution date in the proportion that the total number of units held by such holder bears to the total outstanding units of the same class. Any unit payments will be paid, if at all, on the earlier of (i) the last day of the calendar quarter in which dividends were paid to the Company stockholders and (ii) three business days following the holder’s termination of employment with the Company. For the year ended December 31, 2014, $5.6 million was paid by LG Aviv L.P. to the holders of such units.

 

The following table represents the time and performance-based option awards activity for the years ended December 31, 2014, 2013 and 2012:

 

   2014   2013   2012 
Outstanding at January 1   5,870,138    1,956,805    1,417,228 
Granted           701,550 
Awards vested at IPO       3,913,333     
Exercised   (174,467)        
Cancelled/Forfeited           (161,973)
Outstanding at December 31   5,695,671    5,870,138    1,956,805 
Options exercisable at end of period   5,695,671         
Weighted average fair value of options granted  $2.20   $2.20   $2.20 

 

The following table represents the time and performance based option awards outstanding cumulatively life-to-date for the years ended December 31, 2014, 2013, and 2012 as well as other MIP data:

 

   2014   2013   2012 
Range of exercise prices  $16.56 - $18.87   $16.56 - $18.87   $16.56 - $18.87 
Outstanding   5,695,671    5,870,138    1,956,805 
Remaining contractual life (years)   6.27    7.06    8.06 
Weighted average exercise price  $17.44   $17.47   $17.42 

 

The Company has used the Black-Scholes option pricing model to estimate the grant date fair value of the options. In connection with the IPO, all options outstanding under the MIP became fully-vested and the plan was retired. There were no options awarded in 2013 or 2014. The following table includes the assumptions that were made in estimating the grant date fair value for options awarded in 2012.

 

   2012 Grants 
Weighted average dividend yield   7.54%
Weighted average risk-free interest rate   1.31%
Weighted average expected life   7 years 
Weighted average estimated volatility   38.24%
Weighted average exercise price  $18.78 
Weighted average fair value of options granted (per option)  $2.88 

 

The Company recorded non-cash compensation expenses of approximately $0, $9.0 million, and $1.3 million for the years ended December 31, 2014, 2013 and 2012, related to the time and performance based stock options accounted for as equity awards, as a component of general and administrative expenses in the consolidated statements of operations and comprehensive income, respectively.

 

At December 31, 2014, the total compensation cost related to outstanding, non-vested time based equity option awards that are expected to be recognized as compensation cost in the future aggregates to $0.

 

Dividend equivalent rights associated with the Plan that became payable upon vesting amounted to $0, $15.4 million and $2.3 million for the years ended December 31, 2014, 2013, and 2012, respectively.

 

F-35
  

  

16. Earnings Per Common Share of the REIT

 

The following table shows the amounts used in computing the basic and diluted earnings per common share (in thousands except for share and per share amounts).

 

   For the Year Ended December 31, 
   2014   2013   2012 
Numerator for earnings per share—basic:               
Income from continuing operations  $44,874   $23,071   $4,007 
Income from continuing operations allocable to noncontrolling interests   (9,082)   (6,010)   (1,611)
Income from continuing operations allocable to common stockholders, net of noncontrolling interests   35,792    17,061    2,396 
Discontinued operations, net of noncontrolling interests           2,742 
Numerator for earnings per share—basic  $35,792   $17,061   $5,138 
Numerator for earnings per share—diluted:               
Numerator for earnings per share—basic  $35,792   $17,061   $2,396 
Income from continuing operations allocable to noncontrolling interests—OP Units   9,082    4,610     
Subtotal   44,874    21,671    2,396 
Discontinued operations, net of noncontrolling interests           2,742 
Numerator for earnings per share—diluted  $44,874   $21,671   $5,138 
Denominator for earnings per share—basic and diluted:               
Denominator for earnings per share—basic   44,629,901    33,700,834    20,006,538 
Effect of dilutive securities:               
Noncontrolling interests—OP Units   11,328,049    9,091,974     
Stock options   2,136,040    1,518,813    129,151 
Restricted stock units   72,934    12,568     
Denominator for earnings per share—diluted   58,166,924    44,324,189    20,135,689 
Basic earnings per share               
Income from continuing operations allocable to common stockholders  $0.80   $0.51   $0.12 
Discontinued operations, net of noncontrolling interests           0.14 
Net income allocable to common stockholders  $0.80   $0.51   $0.26 
Diluted earnings per share               
Income from continuing operations allocable to common stockholders  $0.77   $0.49   $0.12 
Discontinued operations, net of noncontrolling interests           0.14 
Net income allocable to common stockholders  $0.77   $0.49   $0.26 

 

F-36
  

  

17. Earnings Per Unit of the Partnership

 

The following table shows the amounts used in computing the basic and diluted earnings per unit (in thousands except for unit and per unit amounts).

 

   For the Year Ended December 31, 
   2014   2013   2012 
Numerator for earnings per unit—basic:               
Income from continuing operations  $44,874   $23,071   $4,007 
Income from continuing operations allocable to limited partners       (1,400)   (1,611)
Income from continuing operations allocable to units   44,874    21,671    2,396 
Discontinued operations           2,742 
Numerator for earnings per unit—basic:  $44,874   $21,671   $5,138 
Numerator for earnings per unit—diluted:               
Income from continuing operations allocable to units  $44,874   $21,671   $2,396 
Discontinued operations           2,742 
Numerator for earnings per unit—diluted  $44,874   $21,671   $5,138 
Denominator for earnings per unit—basic and diluted:               
Denominator for basic earnings per unit—basic   55,957,950    42,792,808    20,006,538 
Effective dilutive securities:               
Stock options   2,136,040    1,518,813    129,151 
Restricted stock units   72,934    12,568     
Denominator for earnings per unit—diluted   58,166,924    44,324,189    20,135,689 
Basic earnings per unit:               
Income from continuing operations allocable to units  $0.80   $0.51   $0.12 
Discontinued operations           0.14 
Net income allocable to units  $0.80   $0.51   $0.26 
Diluted earnings per unit:               
Income from continuing operations allocable to units  $0.77   $0.49   $0.12 
Discontinued operations           0.14 
Net income allocable to units  $0.77   $0.49   $0.26 

 

F-37
  

  

18. Discontinued Operations

 

Prior to the Company adopting ASU No. 2014-08, ASC 205-20, required that the operations and associated gains and/or losses from the sale or planned disposition of components of an entity, as defined, be reclassified and presented as discontinued operations in the Company’s consolidated financial statements for all periods presented. In April 2012, the Company sold three properties in Arkansas and one property in Massachusetts to unrelated third parties. All other sales were immaterial to the consolidated financial statements. Below is a summary of the components of the discontinued operations for the respective periods:

 

   Year Ended December 31, 
   2014   2013   2012 
   (in thousands) 
Total revenues  $   $   $270 
Expenses:               
Interest expense incurred           (27)
Amortization of deferred financing costs           (2)
Depreciation and amortization           (34)
Gain on sale of assets, net           4,425 
Loss on extinguishment of debt           (13)
Other expenses           (33)
Total gains (expenses)           4,316 
Discontinued operations           4,586 
Discontinued operations allocation to noncontrolling interests           1,844 
Discontinued operations allocation to controlling interests  $   $   $2,742 

 

19. Quarterly Results of Operations (Unaudited)

 

The following is a summary of the Company’s unaudited quarterly results of operations for the years ended December 31, 2014 and 2013 (in thousands) including the effects of discontinued operations. The sum of individual quarterly amounts may not agree to the annual amounts included in the consolidated statements of income due to rounding and weighted-average of noncontrolling interest allocation.

 

   Year Ended December 31, 2014 
   1st
Quarter
   2nd
Quarter
   3rd
Quarter
   4th
Quarter
 
Total revenues  $41,876   $43,190   $47,371   $51,605 
Net income  $11,457   $8,460   $12,035   $12,922 
Net income allocable to stockholders  $8,773   $6,761   $9,691   $10,524 
Earnings per common share allocable to stockholders                    
Basic  $0.23   $0.15   $0.21   $0.22 
Diluted  $0.22   $0.14   $0.20   $0.21 

 

   Year Ended December 31, 2013 
   1st
Quarter(1)
   2nd
Quarter
   3rd
Quarter(2)
   4th
Quarter
 
Total revenues  $34,700   $35,033   $32,873   $38,461 
Net income  $(11,440)  $13,405   $10,067   $11,039 
Net income allocable to stockholders  $(7,477)  $10,147   $7,621   $6,770 
Earnings per common share allocable to stockholders                    
Basic  $(0.33)  $0.27   $0.20   $0.22 
Diluted  $(0.33)  $0.26   $0.20   $0.22 

 

(1) The results include $11.0 million loss on extinguishment of debt and $9.9 million of non-cash stock-based compensation as a result of the IPO in the first quarter.

 

(2) The results include $2.9 million of straight-line rent receivable write-offs due to early termination of leases and replacement of operators in the third quarter.

 

F-38
  

  

20. Subsequent Events

 

On January 30, 2015, the Company paid in full the HUD loan, as described in Footnote 9.

 

On February 1, 2015, the Company acquired one property in Washington for a purchase price of $4.3 million from an unrelated third party.

 

21. Condensed Consolidating Information

 

AVIV and certain of the Partnership’s direct and indirect wholly owned subsidiaries (the Subsidiary Guarantors) fully and unconditionally guaranteed, on a joint and several basis, the obligation to pay principal and interest with respect to the Issuer’s 2019 Notes and 2021 Notes issued in February 2011, April 2011, March 2012 and October 2013. The 2019 Notes and 2021 Notes were issued by the Partnership and Aviv Healthcare Capital Corporation. Separate financial statements of the guarantors are not provided as the consolidating financial information contained herein provides a more meaningful disclosure to allow investors to determine the nature of the assets held by and the operations of the respective guarantor and non-guarantor subsidiaries. Other wholly owned subsidiaries (Non-Guarantor Subsidiaries) that were not included among the Subsidiary Guarantors were not obligated with respect to the 2019 Notes and 2021 Notes. The properties held by the Non-Guarantor Subsidiaries are subject to mortgages. The following summarizes the Partnership’s condensed consolidating information as of December 31, 2014, and 2013 and for the years ended December 31, 2014, 2013, and 2012.

 

CONDENSED CONSOLIDATING BALANCE SHEET

As of December 31, 2014

(in thousands)

   Issuers   Subsidiary
Guarantors
   Non-
Guarantor
Subsidiaries
   Eliminations     Consolidated 
Assets                         
Net rental properties  $47   $1,559,950   $322,450   $   $1,882,447 
Cash and cash equivalents   6,678    2,132    1,226        10,036 
Deferred financing costs, net   16,664        2,360        19,024 
Other   23,823    77,394    7,706        108,923 
Investment in and due from related parties, net   1,728,309            (1,728,309)    
Total assets  $1,775,521   $1,639,476   $333,742   $(1,728,309)  $2,020,430 
Liabilities and partners’ capital                         
Secured loan  $   $   $193,418   $   $193,418 
Unsecured notes payable   652,292                652,292 
Line of credit   355,000                355,000 
Accrued Interest Payable   15,080        46        15,126 
Dividends                    
Accounts payable and accrued expenses   1,790    16,505    287        18,582 
Tenant security and escrow deposits   55    25,839    365        26,259 
Other liabilities   1,356    8,449            9,805 
Total liabilities   1,025,573    50,793    194,116        1,270,482 
Total partners’ capital   749,948    1,588,683    139,626    (1,728,309)   749,948 
Total liabilities and partners’ capital  $1,775,521   $1,639,476   $333,742   $(1,728,309)  $2,020,430 

  

F-39
  

  

CONDENSED CONSOLIDATING BALANCE SHEET

As of December 31, 2013

(in thousands)

 

   Issuers   Subsidiary
Guarantors
   Non-
Guarantor
Subsidiaries
   Eliminations     Consolidated 
Assets                         
Net rental properties  $55   $1,148,057   $15,376   $   $1,163,488 
Cash and cash equivalents   50,709    (714)   769        50,764 
Deferred financing costs, net   12,681    3,948    14        16,643 
Other   25,260    71,372    2,906        99,538 
Investment in and due from related parties, net   1,168,729            (1,168,729)    
Total assets  $1,257,434   $1,222,663   $19,065   $(1,168,729)  $1,330,433 
Liabilities and partners’ capital                         
Secured loan  $   $   $13,654   $   $13,654 
Unsecured notes payable   652,752                652,752 
Line of credit       20,000            20,000 
Accrued Interest Payable   14,750    487    47        15,284 
Dividends   17,694                17,694 
Accounts payable and accrued expenses   2,082    8,473             10,555 
Tenant security and escrow deposits   765    20,572    249        21,586 
Other liabilities   946    9,517            10,463 
Total liabilities   688,989    59,049    13,950        761,988 
Total partners’ capital   568,445    1,163,614    5,115    (1,168,729)   568,445 
Total liabilities and partners’ capital  $1,257,434   $1,222,663   $19,065   $(1,168,729)  $1,330,433 

 

 

F-40
  

  

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS AND COMPREHENSIVE INCOME

For the Year Ended December 31, 2014

(in thousands)

 

   Issuers   Subsidiary
Guarantors
   Non-
Guarantor
Subsidiaries
   Eliminations   Consolidated 
Revenues                         
Rental income  $   $175,286   $2,661   $   $177,947 
Interest on loans and financing lease   1,095    3,376    12        4,483 
Interest and other income   483    1,127    2        1,612 
Total revenues   1,578    179,789    2,675        184,042 
Expenses                         
Interest Expense   47,655    1,167    858        49,680 
Amortization of deferred financing costs   3,266    656    20        3,942 
Depreciation and amortization   8    43,587    428        44,023 
General and administrative   8,840    15,102    97        24,039 
Transaction costs   1,919    4,055    2,627        8,601 
Loss on impairment       2,341            2,341 
Reserve for uncollectible loan receivables and other receivables   3,406    117            3,523 
Loss on sale of assets, net       2,518            2,518 
Loss on extinguishment of debt       501            501 
Total expenses   65,094    70,044    4,030        139,168 
Net (loss) income   (63,516)   109,745    (1,355)       44,874 
Equity in income (loss) of subsidiaries   108,390            (108,390)    
Net income (loss) allocable to units  $44,874   $109,745   $(1,355)  $(108,390)  $44,874 

 

F-41
  

  

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS AND COMPREHENSIVE INCOME

For the Year Ended December 31, 2013

(in thousands)

 

   Issuers   Subsidiary
Guarantors
   Non-
Guarantor
Subsidiaries
   Eliminations   Consolidated 
Revenues                         
Rental income  $   $133,395   $3,118   $   $136,513 
Interest on loans and financing lease   1,104    3,296            4,400 
Interest and other income   5    149            154 
Total revenues   1,109    136,840    3,118        141,067 
Expenses                         
Interest Expense   33,390    6,787    608        40,785 
Amortization of deferred financing costs   1,592    1,867            3,459 
Depreciation and amortization   6    32,607    613        33,226 
General and administrative   15,662    11,138    86        26,886 
Transaction costs   832    2,266    16        3,114 
Loss on impairment       500            500 
Reserve for uncollectible loan receivables and other receivables   (10)   89    (11)       68 
Loss (gain)on sale of assets, net       375    (1,391)       (1,016)
Loss on extinguishment of debt       10,974            10,974 
Other expenses                    
Total expenses   51,472    66,603    (79)       117,996 
Net (loss) income   (50,363)   70,237    3,197        23,071 
Equity in income (loss) of subsidiaries   73,434            (73,434)    
Net income (loss) allocable to units  $23,071   $70,237   $3,197   $(73,434)  $23,071 

 

F-42
  

 

 

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS AND COMPREHENSIVE INCOME

For the Year Ended December 31, 2012

(in thousands)

   Issuers     Subsidiary
Guarantors 
   Non-
Guarantor
Subsidiaries 
   Eliminations   Consolidated 
Revenues                         
Rental income  $   $118,111   $3,099   $   $121,210 
Interest on loans and financing lease   1,490    3,143            4,633 
Interest and other income   4    1,125            1,129 
Total revenues   1,494    122,379    3,099        126,972 
Expenses                         
Interest expense incurred   28,734    18,439    267        47,440 
Amortization of deferred financing costs   1,375    2,168            3,543 
Depreciation and amortization       26,099    793        26,892 
General and administrative   6,434    9,475    46        15,955 
Transaction costs   4,171    2,970    118        7,259 
Loss on impairment       7,156    3,961        11,117 
Reserve for uncollectible loan receivables and other receivables   6,532    3,407    392        10,331 
Loss on extinguishment of debt       28            28 
Other expenses       400            400 
Total expenses   47,246    70,142    5,577        122,965 
(Loss) income from continuing operations   (45,752)   52,237    (2,478)       4,007 
Discontinued operations       (392)   4,978        4,586 
Net (loss) income   (45,752)   51,845    2,500        8,593 
Equity in income (loss) of subsidiaries   54,345            (54,345)    
Net income (loss) allocable to units  $8,593   $51,845   $2,500   $(54,345)  $8,593 
Unrealized loss on derivative instruments       (476)           (476)
Total comprehensive income allocable to units  $8,593   $51,369   $2,500   $(54,345)  $8,117 

  

F-43
  

  

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

For the Year Ended December 31, 2014

(in thousands)

 

   Issuers   Subsidiary
Guarantors
   Non-
Guarantor
Subsidiaries
   Eliminations   Consolidated 
Net cash (used in) provided by operating activities  $(375,474)  $345,533   $134,783   $   $104,842 
Investing activities                        
Purchase of real estate investments       (401,970)   (305,000)       (706,970)
Sale of real estate investments       2,277            2,277 
Capital improvements       (14,311)   (686)       (14,997)
Development Projects       (40,771)   (2,312)       (43,083)
Loan receivables received from others   5,700    6,914    7,028        19,642 
Loan receivables funded to others   (7,636)   (5,907)   (10,833)       (24,376)
Net used in investing activities   (1,936)   (453,768)   (311,803)       (767,507)
Financing activities                         
Borrowings of debt   390,000    98,000    180,000        668,000 
Repayment of debt   (35,000)   (118,000)   (157)       (153,157)
Payment of financing costs   (9,121)   4,507    (2,366)       (6,980)
Capital contributions   60                60 
Proceeds of issuance of common stock   221,720                221,720 
Cost of raising capital   (137,132)   126,574            (10,558)
Shares issued for settlement of vested stock and exercised unit options, net   1,707                1,707 
Cash distributions to partners   (98,855)               (98,855)
Net cash provided by (used in) financing activities   333,379    111,081    177,477        621,937 
Net (decrease) increase in cash and cash equivalents   (44,031)   2,846    457        (40,728)
Cash and cash equivalents:                         
Beginning of period   50,709    (714)   769        50,764 
End of period  $6,678   $2,132   $1,226   $   $10,036 

 

F-44
  

  

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

For the Year Ended December 31, 2013

(in thousands)

 

   Issuers   Subsidiary
Guarantors
   Non-
Guarantor
Subsidiaries
   Eliminations   Consolidated 
Net cash (used in) provided by operating activities  $(59,358)  $142,398   $(13,345)  $   $69,695 
Investing activities                         
Purchase of real estate investments       (197,388)           (197,389)
Sale of real estate investments       1,772    13,777        15,549 
Capital improvements   (8)   (11,957)   (38)       (12,003)
Development Projects       (18,738)           (18,738)
Loan receivables received from others   2,446    1,640             4,087 
Loan receivables funded to others   (7,739)   (2,668)            (10,407)
Net used in investing activities   (5,301)   (227,339)   13,739        (218,901)
Financing activities                         
Borrowings of debt   250,000    220,000            470,000 
Repayment of debt       (488,091)   (150)       (488,241)
Payment of financing costs   (5,145)   (5,302)   (1)       (10,448)
Capital contributions   575                575 
Proceeds of issuance of common stock   303,600                303,600 
Cost of raising capital   (385,310)   359,481            (25,829)
Cash distributions to partners   (65,221)               (65,221)
Net cash provided by (used in) financing activities   98,499    86,088    (151)       184,436 
Net (decrease) increase in cash and cash equivalents   33,840    1,147    243        35,230 
Cash and cash equivalents:                         
Beginning of period   16,869    (1,861)   526        15,534 
End of period  $50,709   $(714)  $769   $   $50,764 

 

F-45
  

  

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

For the Year Ended December 31, 2012

(in thousands)

 

   Issuers     Subsidiary
Guarantors  
   Non-
Guarantor
Subsidiaries  
   Eliminations   Consolidated   
Net cash (used in) provided by operating activities  $(152,298)  $209,394   $(13,305)  $   $43,791 
Investing activities                         
Purchase of real estate       (168,233)   (4,540)       (172,773)
Proceeds from sales of real estate       8,556    23,377        31,933 
Capital improvements   (54)   (13,358)   (146)       (13,558)
Development Projects       (26,982)   (1,085)       (28,067)
Loan receivables received from others   12,754    1,571    307        14,632 
Loan receivables funded to others   (13,065)   (3,792)           (16,857)
Net cash used in investing activities   (365)   (202,238)   17,913        (184,690)
Financing activities                         
Borrowings of debt   101,000    164,224    2,537        267,761 
Repayment of debt       (167,981)   (6,146)       (174,127)
Payment of financing costs   (2,562)   (2,581)           (5,143)
Proceeds of issuance of common stock                    
Capital contributions   109,000                109,000 
Deferred contributions   (35,000)               (35,000)
Cash distributions to partners   (45,262)               (45,262)
Net cash provided by (used in) financing activities   127,176    (6,338)   (3,609)       117,229 
Net decrease in cash and cash equivalents   (25,487)   818    999        (23,670)
Cash and cash equivalents:                         
Beginning of period   42,356    (2,679)   (473)       39,204 
End of period  $16,869   $(1,861)  $526   $   $15,534 

 

F-46
  

 

 

AVIV REIT, INC.

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP

SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS

 

Accounts Receivable and Loans Receivable Allowance for Doubtful Accounts (in thousands)

 

   Balance at
Beginning
of Year
   Charged to
(Recovered from)
Costs and
Expenses
   Deductions
and
Write-offs
   Balance at End
of Year
 
Allowance for uncollectible accounts receivable                    
Year ended December 31, 2014  $326   $117   $   $443 
Year ended December 31, 2013   803    57    (534)   326 
Year ended December 31, 2012   80    3,948    (3,225)   803 
Allowance for uncollectible loan receivable                    
Year ended December 31, 2014  $   $3,406   $   $3,406 
Year ended December 31, 2013   317    11    (328)    
Year ended December 31, 2012   2,176    6,532    (8,391)   317 

 

F-47
  

  

AVIV REIT, INC.

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP

SCHEDULE III

 

Real Estate and Investments (in thousands)

 

               Initial Cost to
Company
   Costs Capitalized
Subsequent to Acquisition
   Amount Carried at
December 31, 2014 (c)
          

Description

  Type of
Asset
  Encumbrances  City  State  Land   Buildings &
Improvements
   Improvements /
Adjustments
   Impairment /
Dispositions
   Land   Buildings &
Improvements
   Accumulated
Depreciation
   Net   Year of
Construction
  Date
Acquired
  Life on
Which
Depreciation
in Statement
of Operations
Computed
Aviv Healthcare Properties LP     (1)  Chicago  IL           61            61    (14)   47      
Issuer subtotal                       61            61    (14)   47          
SunBridge Care/Rehab-Broadway  (a)  (2)  Methuen  MA   31    496        (527)                  1910  1993  40 years
SunBridge - Colonial Heights  (a)  (2)  Lawrence  MA   63    959    91    (225)   63    825    (393)   495   1963  1993  40 years
SunBridge - Fall River  (c)  (2)  Fall River  MA   91    1,309    (1)   (1,399)                     1993  40 years
SunBridge Care Center- Glenwood  (a)  (2)  Lowell  MA   82    1,211        (1,293)                  1964  1993  40 years
SunBridge - Hammond House  (a)  (2)  Worchester  MA   42    664    490    (1,196)                  1965  1993  40 years
SunBridge for North Reading  (a)  (2)  North Reading  MA   113    1,567    496    (253)   113    1,810    (713)   1,210   1966  1993  40 years
Robbin House Nursing and Rehab  (c)  (2)  Quincy  MA   66    1,052        (1,118)                     1993  40 years
SunBridge Care Center - Rosewood  (a)  (2)  Fall River  MA   32    513        (545)                  1882  1993  40 years
SunBridge Care/Rehab-Sandalwood  (a)  (2)  Oxford  MA   64    941    596    (193)   64    1,344    (506)   902   1966  1993  40 years
SunBridge - Spring Valley  (a)  (2)  Worchester  MA   71    1,031    100    (205)   71    926    (441)   556   1960  1993  40 years
SunBridge Care/Rehab-Town Manor  (c)  (2)  Lawrence  MA   90    1,306    (1)   (1,395)                     1993  40 years
SunBridge Care/Rehab-Woodmill  (a)  (2)  Lawrence  MA   61    946    91    (235)   61    802    (381)   482   1965  1993  40 years
SunBridge Care/Rehab-Worcester  (c)  (2)  Worchester  MA   93    1,375    (1)   (1,467)                     1993  40 years
Countryside Community  (a)  (2)  South Haven  MI   221    4,239    13        221    4,252    (1,205)   3,268   1975  2005  40 years
Pepin Manor  (a)  (2)  Pepin  WI   318    1,570    333        318    1,903    (481)   1,740   1978  2005  40 years
Highland Health Care Center  (a)  (2)  Highland  IL   190    1,724            190    1,724    (530)   1,384   1963  2005  40 years
Nebraska Skilled Nursing/Rehab  (a)  (2)  Omaha  NE   211    6,695        (2)   209    6,695    (2,136)   4,768   1971  2005  40 years
Casa Real  (a)  (2)  Santa Fe  NM   1,030    2,692    772        1,030    3,464    (1,071)   3,423   1985  2005  40 years
Clayton Nursing and Rehab  (a)  (2)  Clayton  NM   41    790    35        41    825    (334)   532   1960  2005  40 years
Country Cottage Care/Rehab Center  (a)  (2)  Hobbs  NM   9    672            9    672    (326)   355   1963  2005  40 years
Bloomfield Nursing/Rehab Center  (a)  (2)  Bloomfield  NM   344    4,736    19        344    4,755    (1,399)   3,700   1985  2005  40 years
Espanola Valley Center  (a)  (2)  Espanola  NM   216    4,143    17        216    4,160    (1,342)   3,034   1984  2005  40 years
Sunshine Haven Lordsburg  (a)  (2)  Lordsburg  NM   57    1,882            57    1,882    (513)   1,426   1972  2005  40 years
Silver City Care Center  (a)  (2)  Silver City  NM   305    5,844            305    5,844    (1,673)   4,476   1984  2005  40 years
Seven Oaks Nursing and Rehab  (a)  (2)  Bonham  TX   63    2,583            63    2,583    (784)   1,862   1970  2005  40 years
Birchwood Nursing and Rehab  (a)  (2)  Cooper  TX   96    2,727    8        96    2,735    (813)   2,018   1966  2005  40 years
Smith Nursing and Rehab  (a)  (2)  Wolfe City  TX   49    1,010    (8)   (1,051)                  1946  2005  40 years
Clifton Nursing and Rehab  (a)  (2)  Clifton  TX   125    2,975            125    2,975    (964)   2,136   1995  2005  40 years
Stanton Nursing and Rehab  (a)  (2)  Stanton  TX   261    1,018    11        261    1,029    (336)   954   1972  2005  40 years
Valley Mills Nursing and Rehab  (a)  (2)  Valley Mills  TX   34    1,091    (9)       34    1,082    (340)   776   1971  2005  40 years
Hometown Care Center  (a)  (2)  Moody  TX   13    328        (341)                     2005  40 years
Shuksan Healthcare Center  (a)  (2)  Bellingham  WA   61    491    1,984        61    2,475    (491)   2,045   1965  2005  40 years
Orange Villa Nursing and Rehab  (a)  (2)  Orange  TX   98    1,948    18        98    1,966    (613)   1,451   1973  2005  40 years
Pinehurst Nursing and Rehab  (a)  (2)  Orange  TX   99    2,072    23        99    2,095    (674)   1,520   1955  2005  40 years
Wheeler Nursing and Rehab  (a)  (2)  Wheeler  TX   17    1,369            17    1,369    (454)   932   1982  2005  40 years
ABC Health Center  (a)  (2)  Harrisonville  MO   144    1,922    328        144    2,250    (576)   1,818   1970  2005  40 years
Camden Health Center  (a)  (2)  Harrisonville  MO   189    2,532    232        189    2,764    (721)   2,232   1977  2005  40 years
Cedar Valley Health Center  (a)  (2)  Rayton  MO   252    3,376    314        252    3,690    (1,051)   2,891   1978  2005  40 years
Monett Healthcare Center  (a)  (2)  Monett  MO   259    3,470    85        259    3,555    (1,004)   2,810   1976  2005  40 years
White Ridge Health Center  (a)  (2)  Lee’s Summit  MO   292    3,915    66        292    3,981    (1,125)   3,148   1986  2005  40 years
The Orchards Rehab/Care Center  (a)  (2)  Lewiston  ID   201    4,319    507        201    4,826    (1,586)   3,441   1958  2005  40 years
SunBridge for Payette  (a)  (2)  Payette  ID   179    3,166    (27)       179    3,139    (814)   2,504   1964  2005  40 years
Magic Valley Manor-Assisted Living  (b)  (2)  Wendell  ID   177    405    1,021        177    1,426    (285)   1,318   1911  2005  40 years
McCall Rehab and Living Center  (a)  (2)  McCall  ID   213    676    (6)   (883)                  1965  2005  40 years
Menlo Park Health Care  (a)  (2)  Portland  OR   112    2,205    221        112    2,426    (861)   1,677   1959  2005  40 years
Burton Care Center  (a)  (2)  Burlington  WA   115    1,170    86        115    1,256    (359)   1,012   1930  2005  40 years
Columbia View Care Center  (a)  (2)  Cathlamet  WA   49    505        (554)                  1965  2005  40 years
Grandview Healthcare Center  (a)  (2)  Grandview  WA   19    1,155    15        19    1,170    (596)   593   1964  2005  40 years
Hillcrest Manor  (a)  (2)  Sunnyside  WA   102    1,639    6,895        102    8,534    (1,292)   7,344   1970  2005  40 years
Evergreen Hot Springs Center  (a)  (2)  Hot Springs  MT   104    1,943    230        104    2,173    (564)   1,713   1963  2005  40 years
Evergreen Polson Center  (a)  (2)  Polson  MT   121    2,358    575        121    2,933    (722)   2,332   1971  2005  40 years
Evergreen The Dalles Center  (a)  (2)  The Dalles  OR   200    3,832    92        200    3,924    (1,061)   3,063   1964  2005  40 years
Evergreen Vista Health Center  (a)  (2)  LaGrande  OR   281    4,784    248        281    5,032    (1,414)   3,899   1961  2005  40 years
Whitman Health and Rehab Center  (a)  (2)  Colfax  WA   231    6,271    38        231    6,309    (1,622)   4,918   1985  2005  40 years
Fountain Retirement Hotel  (b)  (2)  Youngtown  AZ   101    1,940    170    (2,211)                  1971  2005  40 years
Gilmer Care Center  (a)  (2)  Gilmer  TX   257    2,993    372        257    3,365    (927)   2,695   1967  2005  40 years
Columbus Nursing and Rehab Center  (a)  (2)  Columbus  WI   352    3,477    345        352    3,822    (976)   3,198   1950  2005  40 years
Infinia at Faribault  (a)  (2)  Faribault  MN   70    1,485    102        70    1,587    (523)   1,134   1958  2005  40 years
Infinia at Owatonna  (a)  (2)  Owatonna  MN   125    2,321    (19)       125    2,302    (686)   1,741   1963  2005  40 years
Infinia at Willmar  (a)  (2)  Wilmar  MN   70    1,341    20    (1,431)                  1998  2005  40 years
Infinia at Florence Heights  (a)  (2)  Omaha  NE   413    3,516    4    (3,933)                  1999  2005  40 years
Infinia at Ogden  (a)  (2)  Ogden  UT   234    4,478    601        234    5,079    (1,304)   4,009   1977  2005  40 years
Prescott Manor Nursing Center  (a)  (2)  Prescott  AR   44    1,462    209        44    1,671    (626)   1,089   1965  2005  40 years
Star City Nursing Center  (a)  (2)  Star City  AR   28    1,069    80        28    1,149    (342)   835   1969  2005  40 years
Westview Manor of Peabody  (a)  (2)  Peabody  KS   22    502    140        22    642    (159)   505   1963  2005  40 years
Orchard Grove Extended Care Center  (a)  (2)  Benton Harbor  MI   166    3,185    457    (3,808)                  1971  2005  40 years
Marysville Care Center  (a)  (2)  Marysville  CA   281    1,320        (1,601)                     2005  40 years
Yuba City Care Center  (a)  (2)  Yuba City  CA   177    2,130        (2,307)                     2005  40 years
Lexington Care Center  (a)  (2)  Lexington  MO   151    2,943    491        151    3,434    (1,001)   2,584   1970  2005  40 years
Twin Falls Care Center  (a)  (2)  Twin Falls  ID   448    5,145            448    5,145    (1,464)   4,129   1961  2005  40 years
Gordon Lane Care Center  (a)  (2)  Fullerton  CA   2,982    3,648            2,982    3,648    (1,021)   5,609   1966  2005  40 years
Sierra View Care Center  (a)  (2)  Baldwin Park  CA   868    1,748    7        868    1,755    (571)   2,052   1938  2005  40 years
Villa Maria Care Center  (a)  (2)  Long Beach  CA   140    767    (1)   (906)                     2005  40 years
High Street Care Center  (a)  (2)  Oakland  CA   246    685    14        246    699    (204)   741   1961  2005  40 years
MacArthur Care Center  (a)  (2)  Oakland  CA   246    1,416    85        246    1,501    (558)   1,189   1960  2005  40 years
Country Oaks Nursing Center  (a)  (2)  Ponoma  CA   1,393    2,426            1,393    2,426    (699)   3,120   1964  2005  40 years
Deseret at Hutchinson  (a)  (2)  Hutchinson  KS   180    2,547    92        180    2,639    (798)   2,021   1963  2005  40 years
Woodland Hills Health/Rehab  (a)  (2)  Little Rock  AR   270    4,006        (4,276)                  1979  2005  40 years
Chenal Heights  (a)  (2)  Little Rock  AR   1,411        7,330    (8,741)                  2008  2006  40 years
Blanchette Place Care Center  (a)  (2)  St. Charles  MO   1,300    10,777    194        1,300    10,971    (2,453)   9,818   1994  2006  40 years
Cathedral Gardens Care Center  (a)  (2)  St. Louis  MO   1,600    9,525    68        1,600    9,593    (2,245)   8,948   1979  2006  40 years
Heritage Park Skilled Care  (a)  (2)  Rolla  MO   1,200    7,841    2,538        1,200    10,379    (1,949)   9,630   1993  2006  40 years
Oak Forest Skilled Care  (a)  (2)  Ballwin  MO   550    3,995    116        550    4,111    (955)   3,706   2004  2006  40 years
Richland Care and Rehab  (a)  (2)  Olney  IL   350    2,484            350    2,484    (659)   2,175   2004  2006  40 years
Bonham Nursing and Rehab  (a)  (2)  Bonham  TX   76    1,130            76    1,130    (264)   942   1969  2006  40 years
Columbus Nursing and Rehab  (a)  (2)  Columbus  TX   150    1,809        (1,959)                  1974  2006  40 years
Denison Nursing and Rehab  (a)  (2)  Denison  TX   178    1,945            178    1,945    (457)   1,666   1958  2006  40 years
Falfurrias Nursing and Rehab  (a)  (2)  Falfurias  TX   92    1,065            92    1,065    (273)   884   1974  2006  40 years
Kleburg County Nursing/Rehab  (a)  (2)  Kingsville  TX   315    3,689    2,699        315    6,388    (1,041)   5,662   1947  2006  40 years
Terry Haven Nursing and Rehab  (a)  (2)  Mount Vernon  TX   180    1,971        (2,151)                  2004  2006  40 years
Clarkston Care Center  (a)  (2)  Clarkston  WA   162    7,038    5,518        162    12,556    (2,482)   10,236   1970  2006  40 years
Highland Terrace Nursing Center  (a)  (2)  Camas  WA   593    3,921    6,277        593    10,198    (1,957)   8,834   1970  2006  40 years
Richland Rehabilitation Center  (a)  (2)  Richland  WA   693    9,307    813        693    10,120    (2,102)   8,711   2004  2006  40 years
Evergreen Milton-Freewater Center  (a)  (2)  Milton Freewater  OR   700    5,404            700    5,404    (1,287)   4,817   1965  2006  40 years

 

F-48
  

  

               Initial Cost to
Company
   Costs Capitalized
Subsequent to Acquisition
   Amount Carried at
December 31, 2014 (c)
          

Description

  Type of
Asset
  Encumbrances  City  State  Land   Buildings &
Improvements
   Improvements /
Adjustments
   Impairment /
Dispositions
   Land   Buildings &
Improvements
   Accumulated
Depreciation
   Net   Year of
Construction
  Date
Acquired
  Life on
Which
Depreciation
in Statement
of Operations
Computed
Hillside Living Center  (a)  (2)  Yorkville  IL   560    3,074    (1)   (3)   560    3,070    (797)   2,833   1963  2006  40 years
Arbor View Nursing / Rehab Center  (a)  (2)  Zion  IL   147    5,235    131    (5,513)                  1970  2006  40 years
Ashford Hall  (a)  (2)  Irving  TX   1,746    11,419    114    (143)   1,746    11,390    (2,595)   10,541   1964  2006  40 years
Belmont Nursing and Rehab Center  (a)  (2)  Madison  WI   480    1,861    336        480    2,197    (532)   2,145   1974  2006  40 years
Blue Ash Nursing and Rehab Center  (a)  (2)  Cincinnati  OH   125    6,278    448    (340)   123    6,388    (1,767)   4,744   1969  2006  40 years
West Chester Nursing/Rehab Center  (a)  (2)  West Chester  OH   375    5,663    369    (6,407)                  1965  2006  40 years
Wilmington Nursing/Rehab Center  (a)  (2)  Willmington  OH   125    6,078    673        125    6,751    (1,792)   5,084   1951  2006  40 years
Extended Care Hospital of Riverside  (a)  (2)  Riverside  CA   1,091    5,647    (1)   (26)   1,091    5,620    (1,953)   4,758   1967  2006  40 years
Heritage Manor  (a)  (2)  Monterey Park  CA   1,586    9,274        (23)   1,586    9,251    (2,848)   7,989   1965  2006  40 years
French Park Care Center  (a)  (2)  Santa Ana  CA   1,076    5,984    596        1,076    6,580    (1,517)   6,139   1967  2006  40 years
North Valley Nursing Center  (a)  (2)  Tujunga  CA   614    5,031        (25)   614    5,006    (1,377)   4,243   1967  2006  40 years
Brighten at Medford  (a)  (2)  Medford  MA   2,366    6,613    291    (9,270)                  1978  2007  40 years
Brighten at Ambler  (a)  (2)  Ambler  PA   370    5,112    (653)       370    4,459    (955)   3,874   1963  2007  40 years
Brighten at Broomall  (a)  (2)  Broomall  PA   608    3,930    591        608    4,521    (1,068)   4,061   1955  2007  40 years
Brighten at Bryn Mawr  (a)  (2)  Bryn Mawr  PA   708    6,352    1,469        708    7,821    (1,683)   6,846   1972  2007  40 years
Brighten at Julia Ribaudo  (a)  (2)  Lake Ariel  PA   369    7,560    730        369    8,290    (1,830)   6,829   1980  2007  40 years
Good Samaritan Nursing Home  (a)  (2)  Avon  OH   394    8,856    1,177        394    10,033    (2,156)   8,271   1964  2007  40 years
Belleville Illinois  (a)  (2)  Belleville  IL   670    3,431            670    3,431    (727)   3,374   1978  2007  40 years
Homestead Various Leases (b)  (a)  (2)     TX   345    4,353    229        345    4,582    (922)   4,005      2007  40 years
Byrd Haven Nursing Home  (a)  (2)  Searcy  AR   773    2,413    132    (3,318)                  1961  2008  40 years
Evergreen Arvin Healthcare  (a)  (2)  Arvin  CA   900    4,765    784        1,029    5,420    (1,028)   5,421   1984  2008  40 years
Evergreen Bakersfield Healthcare  (a)  (2)  Bakersfield  CA   1,000    12,154    1,839        1,153    13,840    (2,366)   12,627   1987  2008  40 years
Evergreen Lakeport Healthcare  (a)  (2)  Lakeport  CA   1,100    5,237    877        1,257    5,957    (1,155)   6,059   1987  2008  40 years
New Hope Care Center  (a)  (2)  Tracy  CA   1,900    10,294    1,687        2,172    11,709    (2,039)   11,842   1987  2008  40 years
Olive Ridge Care Center  (a)  (2)  Oroville  CA   800    8,609    2,298        922    10,785    (1,913)   9,794   1987  2008  40 years
Twin Oaks Health & Rehab  (a)  (2)  Chico  CA   1,300    8,398    1,394        1,488    9,604    (1,822)   9,270   1988  2008  40 years
Evergreen Health & Rehab  (a)  (2)  LaGrande  OR   1,400    808    307        1,591    924    (222)   2,293   1975  2008  40 years
Evergreen Bremerton Health & Rehab  (a)  (2)  Bremerton  WA   650    1,366        (2,016)                  1969  2008  40 years
Four Fountains  (a)  (2)  Belleville  IL   989    5,007            989    5,007    (850)   5,146   1972  2008  40 years
Brookside Health & Rehab  (a)  (2)  Little Rock  AR   751    4,421    1,614        751    6,035    (1,127)   5,659   1969  2008  40 years
Skilcare Nursing Center  (a)  (2)  Jonesboro  AR   417    7,007    374        417    7,381    (1,340)   6,458   1973  2008  40 years
Stoneybrook Health & Rehab Center  (a)  (2)  Benton  AR   250    3,170    313        250    3,483    (1,484)   2,249   1968  2008  40 years
Trumann Health & Rehab  (a)  (2)  Trumann  AR   167    3,587    346        167    3,933    (680)   3,420   1971  2008  40 years
Deseret at McPherson  (a)  (2)  McPherson  KS   92    1,875    148        92    2,023    (344)   1,771   1970  2008  40 years
Mission Nursing Center  (a)  (2)  Riverside  CA   230    1,210    69        230    1,279    (225)   1,284   1957  2008  40 years
New Byrd Haven Nursing Home  (a)  (2)  Searcy  AR       10,213    630        630    10,213    (1,888)   8,955   2009  2009  40 years
Hidden Acres Health Care  (a)  (2)  Mount Pleasant  TN   67    3,313            67    3,313    (403)   2,977   1979  2010  40 years
Heritage Gardens of Portageville  (a)  (2)  Portageville  MO   224    3,089            224    3,089    (369)   2,944   1995  2010  40 years
Heritage Gardens of Greenville  (a)  (2)  Greenville  MO   119    2,219            119    2,219    (271)   2,067   1990  2010  40 years
Heritage Gardens of Senath  (a)  (2)  Senath  MO   109    2,773    266        109    3,039    (372)   2,776   1980  2010  40 years
Heritage Gardens of Senath South  (a)  (2)  Senath  MO   73    1,855            73    1,855    (231)   1,697   1980  2010  40 years
The Carrington  (a)  (2)  Lynchburg  VA   706    4,294            706    4,294    (469)   4,531   1994  2010  40 years
Arma Care Center  (a)  (2)  Arma  KS   57    2,898            57    2,898    (344)   2,611   1970  2010  40 years
Yates Center Nursing and Rehab  (a)  (2)  Yates  KS   54    2,990            54    2,990    (353)   2,691   1967  2010  40 years
Great Bend Health & Rehab Center  (a)  (2)  Great Bend  KS   111    4,589    299        111    4,888    (705)   4,294   1965  2010  40 years
Maplewood at Norwalk  (b)  (2)  Norwalk  CT   1,590    1,010    15,789        1,590    16,799    (1,001)   17,388   1983  2010  40 years
Carrizo Springs Nursing & Rehab  (a)  (2)  Carrizo Springs  TX   45    1,955            45    1,955    (253)   1,747   1965  2010  40 years
Wellington Leasehold  (a)  (2)  Wellington  KS           2,000            2,000    (352)   1,648   1957  2010  21 years
St. James Nursing & Rehab  (a)  (2)  Carrabelle  FL   1,144    8,856            1,144    8,856    (1,075)   8,925   2009  2011  40 years
University Manor  (a)  (2)  Cleveland  OH   886    8,695            886    8,695    (919)   8,662   1982  2011  40 years
Grand Rapids Care Center  (a)  (2)  Grand Rapids  OH   288    1,517            288    1,517    (170)   1,635   1993  2011  40 years
Bellevue Care Center  (a)  (2)  Bellevue  OH   282    3,440            282    3,440    (346)   3,376   1988  2011  40 years
Orchard Grove Assisted Living  (b)  (2)  Bellevue  OH   282    3,440            282    3,440    (346)   3,376   1998  2011  40 years
Woodland Manor Nursing and Rehabilitation  (a)  (2)  Conroe  TX   577    2,091    280        577    2,371    (299)   2,649   1975  2011  40 years
Fredericksburg Nursing and Rehabilitation  (a)  (2)  Fredericksburg  TX   327    3,046    30        327    3,076    (328)   3,075   1970  2011  40 years
Jasper Nursing and Rehabilitation  (a)  (2)  Jasper  TX   113    2,554    29    (2,696)                  1972  2011  40 years
Legacy Park Community Living Center  (a)  (2)  Peabody  KS   33    1,267    440        33    1,707    (156)   1,584   1963  2011  40 years
Oak Manor Nursing and Rehabilitation  (a)  (2)  Commerce  TX   225    1,868    444        225    2,312    (257)   2,280   1963  2011  40 years
Loma Linda Healthcare  (a)  (2)  Moberly  MO   913    4,557    6        913    4,563    (490)   4,986   1987  2011  40 years
Transitions Healthcare Gettysburg  (a)  (2)  Gettysburg  PA   242    5,858    347        242    6,205    (608)   5,839   1950  2011  40 years
Maplewood at Darien  (b)  (2)  Darien  CT   2,430    3,070    12,263        2,430    15,333    (1,038)   16,725   2012  2011  40 years
Scranton Healthcare Center  (a)  (2)  Scranton  PA   1,120    5,537            1,120    5,537    (459)   6,198   2002  2011  40 years
Burford Manor  (a)  (2)  Davis  OK   80    3,220            80    3,220    (272)   3,028   1969  2011  40 years
Care Meridian Cowan Heights  (h)  (2)  Santa Ana  CA   220    1,129            220    1,129    (112)   1,237   1989  2011  40 years
Care Meridian La Habra Heights  (h)  (2)  La Habra  CA   200    1,339            200    1,339    (130)   1,409   1990  2011  40 years
Care Meridian Oxnard  (h)  (2)  Oxnard  CA   100    1,219            100    1,219    (121)   1,198   1994  2011  40 years
Care Meridian Marin  (h)  (2)  Fairfax  CA   320    2,149            320    2,149    (197)   2,272   2000  2011  40 years
Care Meridian Artesia  (h)  (2)  Artesia  CA   180    1,389            180    1,389    (133)   1,436   2002  2011  40 years
Care Meridian Las Vegas  (a)  (2)  Las Vegas  NV   760    7,776    324        760    8,100    (707)   8,153   2004  2011  40 years
Bath Creek     (2)  Cuyahoga Falls  OH                                  2013  2012  40 years
Astoria Health and Rehab  (a)  (2)  Germantown  OH   330    2,170    278        330    2,448    (216)   2,562   1996  2012  40 years
North Platte Care Centre  (a)/(b)  (2)  North Platte  NE   237    2,129    77        237    2,206    (246)   2,197   1983  2012  40 years
Fair Oaks Care Centre  (b)  (2)  Shenandoah  IA   68    402            68    402    (33)   437   1997  2012  40 years
Crest Haven Care Centre  (a)  (2)  Creston  IA   72    1,467    117        72    1,584    (131)   1,525   1964  2012  40 years
Premier Estates Rock Rapids  (b)  (2)  Rock Rapids  IA   83    2,282            83    2,282    (183)   2,182   1998  2012  40 years
Rock Rapids Care Centre  (a)  (2)  Rock Rapids  IA   113    2,349    151        113    2,500    (197)   2,416   1976  2012  40 years
Elmwood Care Centre  (a)/(b)  (2)  Onawa  IA   227    1,733    190        227    1,923    (179)   1,971   1961  2012  40 years
Sunny Knoll Care Centre  (a)  (2)  Rockwell City  IA   62    2,092            62    2,092    (170)   1,984   1966  2012  40 years
New Hampton Care Centre  (a)  (2)  New Hampton  IA   144    2,739    31        144    2,770    (239)   2,675   1967  2012  40 years
Monte Siesta  (a)  (2)  Austin  TX   770    5,230            770    5,230    (428)   5,572   1964  2012  40 years
Silver Pines  (a)  (2)  Bastrop  TX   480    3,120            480    3,120    (321)   3,279   1987  2012  40 years
Spring Creek  (a)  (2)  Beaumont  TX   300    700            300    700    (72)   928   1969  2012  40 years
Riverview  (a)  (2)  Boerne  TX   480    3,470    300        780    3,470    (335)   3,915   1994  2012  40 years
Bluebonnet  (a)  (2)  Karnes City  TX   420    3,130            420    3,130    (320)   3,230   1994  2012  40 years
Cottonwood  (a)  (2)  Denton  TX   240    2,060            240    2,060    (189)   2,111   1969  2012  40 years
Regency Manor  (a)  (2)  Floresville  TX   780    6,120            780    6,120    (571)   6,329   1995  2012  40 years
DeLeon  (a)  (2)  DeLeon  TX   200    2,800            200    2,800    (240)   2,760   1974  2012  40 years
Spring Oaks  (a)  (2)  Lampasas  TX   360    4,640            360    4,640    (420)   4,580   1990  2012  40 years
Lynwood  (a)  (2)  Levelland  TX   300    3,800            300    3,800    (380)   3,720   1990  2012  40 years
Sienna  (a)  (2)  Odessa  TX   350    8,050            350    8,050    (664)   7,736   1974  2012  40 years
Deerings  (a)  (2)  Odessa  TX   280    8,420    140        280    8,560    (711)   8,129   1975  2012  40 years
Terrace West  (a)  (2)  Midland  TX   440    5,860            440    5,860    (525)   5,775   1975  2012  40 years
Lake Lodge  (a)  (2)  Lake Worth  TX   650    4,610            650    4,610    (420)   4,840   1977  2012  40 years
Nolan  (a)  (2)  Sweetwater  TX   190    4,210            190    4,210    (429)   3,971   2010  2012  40 years
Langdon Hall  (b)  (2)  Bradenton  FL   390    4,546    180        390    4,726    (369)   4,747   1985  2012  40 years
Mount Washington Residence  (b)  (2)  Eau Claire  WI   1,040    1,460    352        1,040    1,812    (153)   2,699   1930  2012  40 years
Highlands Nursing and Rehabilitation Center  (a)  (2)  Louisville  KY   441    9,484    127        441    9,611    (688)   9,364   1977  2012  40 years
Seven Oaks Nursing & Rehabilitation  (a)  (2)  Glendale  WI   1,620    5,980            1,620    5,980    (374)   7,226   1994  2012  40 years

 

F-49
  

  

               Initial Cost to
Company
   Costs Capitalized
Subsequent to Acquisition
   Amount Carried at
December 31, 2014 (c)
          

Description

  Type of
Asset
  Encumbrances  City  State  Land   Buildings &
Improvements
   Improvements /
Adjustments
   Impairment /
Dispositions
   Land   Buildings &
Improvements
   Accumulated
Depreciation
   Net   Year of
Construction
  Date
Acquired
  Life on
Which
Depreciation
in Statement
of Operations
Computed
Nesbit Living and Recovery Center  (a)  (2)  Seguin  TX   600    4,400            600    4,400    (323)   4,677   1958  2012  40 years
The Harbor House of Ocala  (b)  (2)  Dunnellon, FL  FL   690    3,510    285        690    3,795    (246)   4,239   1993  2012  40 years
The Harmony House at Ocala  (b)  (2)  Ocala, FL  FL   500    2,800    37        500    2,837    (179)   3,158   1984  2012  40 years
The Haven House at Ocala  (b)  (2)  Dunnellon, FL  FL   490    2,610    98        490    2,708    (170)   3,028   1991  2012  40 years
Seaside Manor Ormond Beach  (b)  (2)  Ormond Beach, FL  FL   630    2,870    80        630    2,950    (206)   3,374   1996  2012  40 years
Fountain Lake  (a)  (2)  Hot Springs  AR           181            181    (13)   168   2007  2008  40 years
Northridge Healthcare/Rehab  (a)  (2)  Little Rock  AR   465    3,012    55    (3,532)                  1969  2005  40 years
Eagle Lake Nursing and Rehabilitation  (e)  (2)  Eagle Lake  TX   93        6,446        93    6,446    (172)   6,367   2013  2012  40 years
Chatham Acres Nursing Home  (a)  (2)  Chatham  PA   203    1,997    9,871        203    11,868    (2,246)   9,825   1873  2011  40 years
Houston Nursing and Rehab  (a)  (2)  Houston  TX   228    2,452            228    2,452    (892)   1,788   1976  2006  40 years
Raton Nursing and Rehab Center  (a)  (2)  Raton  NM   128    1,509    47        128    1,556    (610)   1,074   1985  2005  40 years
Red Rocks Care Center  (a)  (2)  Gallup  NM   329    3,953    17        329    3,970    (1,233)   3,066   1978  2005  40 years
Heritage Villa Nursing/Rehab  (a)  (2)  Dayton  TX   18    436    9        18    445    (156)   307   1964  2005  40 years
Wellington Oaks Nursing/Rehab  (a)  (2)  Ft. Worth  TX   137    1,147    (9)       137    1,138    (416)   859   1963  2005  40 years
Blanco Villa Nursing and Rehab  (a)  (2)  San Antonio  TX   342    1,931    971        342    2,902    (869)   2,375   1969  2005  40 years
Forest Hill Nursing Center  (a)  (2)  Ft. Worth  TX   88    1,764        (1,852)                     2005  40 years
Garland Nursing and Rehab  (a)  (2)  Garland  TX   57    1,058    1,358        57    2,416    (530)   1,943   1964  2005  40 years
Hillcrest Nursing and Rehab  (a)  (2)  Wylie  TX   210    2,684    528        210    3,212    (848)   2,574   1975  2005  40 years
Mansfield Nursing and Rehab  (a)  (2)  Mansfield  TX   487    2,143    (18)       487    2,125    (686)   1,926   1964  2005  40 years
Westridge Nursing and Rehab  (a)  (2)  Lancaster  TX   626    1,848    (16)       626    1,832    (610)   1,848   1973  2005  40 years
Brownwood Nursing and Rehab  (a)  (2)  Brownwood  TX   140    3,464    1,502        140    4,966    (1,152)   3,954   1968  2005  40 years
Irving Nursing and Rehab  (a)  (2)  Irving  TX   137    1,248    (10)       137    1,238    (419)   956   1972  2005  40 years
North Pointe Nursing and Rehab  (a)  (2)  Watauga  TX   1,061    3,846            1,061    3,846    (1,110)   3,797   1999  2005  40 years
Evergreen Foothills Center  (a)  (2)  Phoenix  AZ   500    4,538            500    4,538    (1,689)   3,349   1997  2005  40 years
Evergreen Sun City Center  (a)  (2)  Sun City  AZ   476    5,698    60        476    5,758    (1,746)   4,488   1985  2005  40 years
Sunset Gardens at Mesa  (b)  (2)  Mesa  AZ   123    1,641    (14)       123    1,627    (472)   1,278   1974  2005  40 years
Evergreen Mesa Christian Center  (a)  (2)  Mesa  AZ   466    6,231    (47)   (615)   466    5,569    (1,921)   4,114   1973  2005  40 years
San Juan Rehab and Care Center  (a)  (2)  Anacortes  WA   625    1,185    2,041        625    3,226    (993)   2,858   1965  2005  40 years
Pomona Vista Alzheimer’s Center  (a)  (2)  Ponoma  CA   403    955            403    955    (311)   1,047   1959  2005  40 years
Rose Convalescent Hospital  (a)  (2)  Baldwin Park  CA   1,308    486            1,308    486    (184)   1,610   1963  2005  40 years
Evergreen Nursing/Rehab Center  (a)  (2)  Effingham  IL   317    3,462            317    3,462    (1,018)   2,761   1974  2005  40 years
Doctors Nursing and Rehab Center  (a)  (2)  Salem  IL   125    4,664    900        125    5,564    (1,446)   4,243   1972  2005  40 years
Willis Nursing and Rehab  (a)  (2)  Willis  TX   212    2,407            212    2,407    (596)   2,023   1975  2006  40 years
Douglas Rehab and Care Center  (a)  (2)  Matoon  IL   250    2,391    1,404    (13)   250    3,782    (681)   3,351   1963  2006  40 years
Villa Rancho Bernardo Care Center  (a)  (2)  San Diego  CA   1,425    9,653    65    (57)   1,425    9,661    (2,301)   8,785   1994  2006  40 years
Austin Nursing Center  (a)  (2)  Austin  TX   1,501    4,505    2,293        1,501    6,798    (1,182)   7,117   2007  2007  40 years
Dove Hill Care Center and Villas  (a)  (2)  Hamilton  TX   58    5,781            58    5,781    (1,186)   4,653   1998  2007  40 years
Evergreen Health & Rehab of Petaluma  (a)  (2)  Petaluma  CA   749    2,460            749    2,460    (562)   2,647   1969  2009  40 years
Evergreen Mountain View Health & Rehab  (a)  (2)  Carson City  NV   3,455    5,942            3,455    5,942    (976)   8,421   1977  2009  40 years
Maplewood at Orange  (b)  (2)  Orange  CT   1,134    11,155    2,543        1,134    13,698    (1,494)   13,338   1999  2010  40 years
Lakewood Senior Living of Pratt  (a)  (2)  Pratt  KS   19    503    312        19    815    (83)   751   1964  2011  40 years
Lakewood Senior Living of Seville  (a)  (2)  Wichita  KS   94    897    151        94    1,048    (139)   1,003   1977  2011  40 years
Lakewood Senior Living of Haviland  (a)  (2)  Haviland  KS   112    649    16        112    665    (86)   691   1971  2011  40 years
Maplewood at Newtown  (b)  (2)  Newtown  CT   4,942    7,058    3,952        6,314    9,638    (976)   14,976   2000  2011  40 years
Crawford Manor  (a)  (2)  Cleveland  OH   120    3,080            120    3,080    (274)   2,926   1994  2011  40 years
Amberwood Manor Nursing Home Rehabilitation  (a)  (2)  New Philadelphia  PA   451    3,264            451    3,264    (274)   3,441   1962  2011  40 years
Caring Heights Community Care & Rehabilitation Center  (a)  (2)  Coroapolis  PA   1,546    10,018            1,546    10,018    (845)   10,719   1983  2011  40 years
Dunmore Healthcare Group  (a)  (2)  Dunmore  PA   398    6,813            398    6,813    (580)   6,631   2002  2011  40 years
Eagle Creek Healthcare Group  (a)  (2)  West Union  OH   1,056    5,774    163        1,056    5,937    (491)   6,502   1981  2011  40 years
Edison Manor Nursing & Rehabilitation  (a)  (2)  New Castle  PA   393    8,246            393    8,246    (705)   7,934   1982  2011  40 years
Indian Hills Health & Rehabilitation Center  (a)  (2)  Euclid  OH   853    8,425            853    8,425    (710)   8,568   1989  2011  40 years
Milcrest Nursing Center  (a)  (2)  Marysville  OH   736    2,169            736    2,169    (188)   2,717   1968  2011  40 years
Deseret Nursing & Rehabilitation at Colby  (a)  (2)  Colby  KS   569    2,799            569    2,799    (231)   3,137   1974  2011  40 years
Deseret Nursing & Rehabilitation at Kensington  (a)  (2)  Kensington  KS   280    1,419            280    1,419    (124)   1,575   1967  2011  40 years
Deseret Nursing & Rehabilitation at Onaga  (a)  (2)  Onaga  KS   87    2,866            87    2,866    (236)   2,717   1959  2011  40 years
Deseret Nursing & Rehabilitation at Oswego  (a)  (2)  Oswego  KS   183    840            183    840    (76)   947   1960  2011  40 years
Deseret Nursing & Rehabilitation at Smith Center  (a)  (2)  Smith Center  KS   106    1,650            106    1,650    (140)   1,616   1960  2011  40 years
Sandalwood Healthcare  (a)  (2)  Little Rock  AR   1,040    3,710    866        1,040    4,576    (463)   5,153   1996  2011  40 years
Gardnerville Health and Rehab  (a)  (2)  Gardnerville  NV   1,238    3,562            1,238    3,562    (295)   4,505   2000  2012  40 years
Aviv Asset Management  (d)  (2)  Chicago  IL           1,294            1,294    (601)   693          
Community Care and Rehab  (a)  (2)  Riverside  CA   1,648    9,852            1,648    9,852    (1,367)   10,133   1965  2010  40 years
Rivercrest Specialty Hospital  (i)  (2)  Mishawaka  IN   328    8,072    1,691        328    9,763    (641)   9,450   1991  2012  40 years
Safe Haven Hospital and Care Center  (a)  (2)  Pocatello  ID   470    5,530    3,577        470    9,107    (522)   9,055   1970  2012  40 years
Care Meridian Pleasanton  (h)  (2)  Pleasanton  CA   411    751    1,475        411    2,226    (127)   2,510   2012  2012  40 years
Inola Health Care Center  (a)  (2)  Inola  OK   520    2,480            520    2,480    (175)   2,825   1990  2012  40 years
Avondale Cottage of Pryor  (b)  (2)  Pryor  OK   100    400            100    400    (23)   477   2000  2012  40 years
The Woodlands at Robinson  (a)  (2)  Ravenna  OH   660    6,940            660    6,940    (434)   7,166   2000  2012  40 years
Texan Nursing & Rehab of Gonzales  (a)  (2)  Gonzales  TX   560    1,840    233        560    2,073    (108)   2,525   1963  2013  40 years
Knox and Winamac Community Health Center  (j)  (2)  Knox  IN   137    1,063            137    1,063    (45)   1,155   2008  2013  40 years
Diplomate Healthcare  (a)  (2)  North Royalton  OH   1,330    13,020            1,330    13,020    (658)   13,692   1979  2013  40 years
Warr Acres Nursing Center  (a)  (2)  Oklahoma City  OK   580    2,420            580    2,420    (135)   2,865   1971  2013  40 years
Windsor Hills Nursing Center  (a)  (2)  Oklahoma City  OK   370    2,830            370    2,830    (167)   3,033   1967  2013  40 years
Oakcreek Nursing and Rehab  (a)  (2)  Luling  TX   272    3,178            272    3,178    (150)   3,300   1972  2013  40 years
Heart of Florida  (b)  (2)  Haines City  FL   510    2,990            510    2,990    (111)   3,389   1954  2013  40 years
Tender Loving Care  (b)  (2)  Lakeland  FL   330    2,270            330    2,270    (83)   2,517   1980  2013  40 years
Tangerine Cove  (b)  (2)  Brooksville  FL   702    6,198            702    6,198    (227)   6,673   1925  2013  40 years
Mercy Franciscan at Schroder  (a)  (2)  Hamilton  OH   1,066    8,862    13        1,066    8,875    (340)   9,601   1971  2013  40 years
Mercy Providence Retirement  (a)  (2)  New Albany  IN   1,152    15,578            1,152    15,578    (564)   16,166   1999  2013  40 years
Mercy Siena Retirement  (a)  (2)  Dayton  OH   1,158    3,455            1,158    3,455    (139)   4,474   1966  2013  40 years
Mercy St. Theresa  (a)  (2)  Cincinnati  OH   1,287    3,341    96        1,287    3,437    (135)   4,589   1929  2013  40 years
Echo Manor  (a)  (2)  Pickerington  OH   550    9,810            550    9,810    (344)   10,016   1978  2013  40 years
Oak Pavillion Nursing Home  (a)  (2)  Cincinnati  OH   530    12,260            530    12,260    (439)   12,351   1967  2013  40 years
Park View Nursing Center  (a)  (2)  Edgerton  OH   390    5,050            390    5,050    (184)   5,256   1920  2013  40 years
Summit’s Trace Nursing Home  (a)  (2)  Columbus  OH   2,070    10,340            2,070    10,340    (388)   12,022   1964  2013  40 years
Yell County Nursing Home  (a)  (2)  Ola  AR   78    1,085    141        78    1,226    (40)   1,264   1965  2013  40 years
Heather Hill  (a)  (2)  Chardon  OH   1,650    13,865            1,650    13,865    (441)   15,074   1955  2013  40 years
Liberty Assisted Living  (b)  (2)  Chardon  OH   630    9,585    1,230        630    10,815    (308)   11,137   1999  2013  40 years
Heather Hill LTACH  (i)  (2)  Chardon  OH   1,100    8,770            1,100    8,770    (247)   9,623   1955  2013  40 years
The Village at Richardson  (a)  (2)  Richardson  TX   1,470    11,530    30        1,470    11,560    (369)   12,661   1980  2013  40 years
Helia Healthcare of Champaign  (a)  (2)  Champaign  IL   350    2,450    73        350    2,523    (79)   2,794   1961  2013  40 years
Helia Healthcare of Energy  (a)  (2)  Energy  IL   100    3,300            100    3,300    (106)   3,294   1971  2013  40 years
Helia Healthcare of W. Franklin  (a)  (2)  West Frankfort  IL   50    750            50    750    (25)   775   1973  2013  40 years
Fort Stockton Nursing Center  (a)  (2)  Fort Stockton  TX   480    2,870    637        480    3,507    (113)   3,874   1992  2013  40 years
North Ridge Care Center  (a)  (2)  New Hope  MN   5,268    18,930    319        5,268    19,249    (607)   23,910   1966  2014  41 years
North Ridge Apartments  (a)  (2)  New Hope  MN   2,175    7,555    682        2,175    8,237    (241)   10,171   1983  2014  42 years
North Ridge ALF  (b)  (2)  New Hope  MN   1,278    4,795            1,278    4,795    (147)   5,926   1983  2014  43 years
Bridgecrest Rehab Suites  (a)  (2)  Houston  TX   1,280    14,640            1,280    14,640    (397)   15,523   2014  2014  44 years
Carrington Place at Muscatine  (a)  (2)  Muscatine  IA   320    8,080            320    8,080    (220)   8,180   1961  2014  45 years

 

F-50
  

  

               Initial Cost to
Company
   Costs Capitalized
Subsequent to Acquisition
   Amount Carried at
December 31, 2014 (c)
          

Description

  Type of
Asset
  Encumbrances  City  State  Land   Buildings &
Improvements
   Improvements /
Adjustments
   Impairment /
Dispositions
   Land   Buildings &
Improvements
   Accumulated
Depreciation
   Net   Year of
Construction
  Date
Acquired
  Life on
Which
Depreciation
in Statement
of Operations
Computed
Carrington Place of Toledo  (a)  (2)  Toledo  IA   340    4,760            340    4,760    (129)   4,971   1975  2014  46 years
Gallatin Health Care  (a)  (2)  Warsaw  KY   550    7,410            550    7,410    (204)   7,756   1989  2014  47 years
Homestead Lexington  (a)  (2)  Lexington  KY   760    6,280            760    6,280    (173)   6,867   1969  2014  48 years
Homestead New Castle  (a)  (2)  New Castle  KY   290    3,110            290    3,110    (80)   3,320   1971  2014  49 years
The Oaks  (b)  (2)  LaGrange  KY   240    1,110            240    1,110    (30)   1,320   1990  2014  50 years
Pine Meadows Health Care  (a)  (2)  Lexington  KY   660    6,620            660    6,620    (182)   7,098   1990  2014  51 years
The Richwood  (a)  (2)  LaGrange  KY   660    5,560            660    5,560    (156)   6,064   1997  2014  52 years
Twin Oaks Assisted Living  (b)  (2)  New Castle  KY   280    1,470            280    1,470    (41)   1,709   2002  2014  53 years
Care Meridian Northridge  (h)  (2)  Northridge  CA   469    310    623        469    933    (33)   1,369   2013  2013  40 years
Pensacola Health Care  (a)  (2)  Pensacola  FL   160    5,840            160    5,840    (160)   5,840   1984  2014  40 years
Edgewood Rehab  (a)  (2)  Mesquite  TX   1,070    12,170            1,070    12,170    (258)   12,982   2012  2014  40 years
Estrella Oaks Rehab  (a)  (2)  Georgetown  TX   1,420    12,660            1,420    12,660    (267)   13,813   2011  2014  40 years
Sandy Lake Rehab  (a)  (2)  Coppell  TX   920    12,030            920    12,030    (251)   12,700   2009  2014  40 years
San Gabriel Rehab  (a)  (2)  Round Rock  TX   1,460    11,970            1,460    11,970    (263)   13,168   2011  2014  40 years
Mulberry Manor  (a)  (2)  Stephenville  TX   580    3,020            580    3,020    (67)   3,533   1965  2014  40 years
Lindsay Gardens  (a)  (2)  Lindsay  CA   480    5,770            480    5,770    (129)   6,121   1996  2014  40 years
Sun Villa  (a)  (2)  Porterville  CA   500    4,100            500    4,100    (85)   4,515   1958  2014  40 years
Valley Care Center  (a)  (2)  Porterville  CA   120    2,380            120    2,380    (50)   2,450   1947  2014  40 years
Royal Manor  (a)  (2)  Nicholasville  KY   280    5,720            280    5,720    (109)   5,891   1974  2014  40 years
Chateau Care Center  (a)  (2)  St. Joseph  MO   40    2,860            40    2,860    (50)   2,850   1955  2014  40 years
The Inn  (a)  (2)  St. Joseph  MO   270    6,330            270    6,330    (105)   6,495   1980  2014  40 years
Riverside Care Center  (a)  (2)  St. Joseph  MO   160    6,540            160    6,540    (98)   6,602   1980  2014  40 years
Maplewood at Mayflower Nursing  (a)  (2)  West Yarmouth  MA   800    13,200    35        800    13,235    (182)   13,853   1988  2014  40 years
Royal Park Care Center  (a)  (2)  Spokane  WA   810    21,990            810    21,990    (226)   22,574   1990  2014  40 years
Alderwood Park Center  (a)  (2)  Bellingham  WA   980    11,400            980    11,400    (119)   12,261   1996  2014  40 years
Merry Haven Care Center  (a)  (2)  Snohomish  WA   750    9,970            750    9,970    (104)   10,616   1986  2014  40 years
Royal Plaza Retirement Center  (b)  (2)  Lewiston  ID   1,480    18,240            1,480    18,240    (181)   19,539   2008  2014  40 years
Royal Plaza Spokane  (b)  (2)  Spokane  WA   770    11,890            770    11,890    (122)   12,538   1996  2014  40 years
Highland Care Center  (a)  (2)  Bellingham  WA   240    5,080            240    5,080    (53)   5,267   1951  2014  40 years
Belle Meade Home  (a)  (2)  Greenville  KY   380    4,220            380    4,220    (35)   4,565   1980  2014  40 years
Premier Care of Dallas  (a)  (2)  Dallas  TX   960    14,140            960    14,140    (76)   15,024   2012  2014  40 years
Premier Care on Hillcrest  (a)  (2)  Dallas  TX   870    12,530            870    12,530    (67)   13,333   2011  2014  40 years
Care Meridian Granite Bay  (h)  (2)  Granite Bay  CA   540    435    2,683        540    3,118    (57)   3,601   1978  2012  40 years
Bethel  (c)  (2)  Bethel  CT   2,400        23,442        2,400    23,442    (41)   25,801   2014  2013  40 years
Care Meridian Chatsworth  (h)  (2)  Chatsworth  CA   416    281    766        416    1,047    (30)   1,433   2013  2013  40 years
Doctors Neuro Hospital  (k)  (2)  Bremen  IN   400    8,900    2,796        400    11,696    (279)   11,817   1988  2013  40 years
Unencumbered Guarantors subtotal               170,103    1,361,012    176,463    (82,056)   164,426    1,461,097    (184,732)   1,440,791          
Little Rock Health and Rehab  (a)  (4)  Little Rock  AR   471    4,779    7,613    (12,863)                  1971  2009  40 years
Pinehurst Park Terrace  (a)  (4)  Seattle  WA       360        (360)                     2005  40 years
North Richland Hills  (a)  (4)  North Richland Hills  TX   980        5,068    (6,048)                     2005  40 years
Skagit Aviv     (4)  Mt. Vernon  WA           422    (422)                     2014  40 years
The Laurels of Defiance  (a)  (4)  Defiance  OH   145    10,736            145    10,736        10,881   1979  2014  40 years
The Laurels of Hillsboro  (a)  (4)  Hillsboro  OH   346    8,087            346    8,087        8,433   1976  2014  40 years
The Laurels of Massillon  (a)  (4)  Massillon  OH   1,492    23,848            1,492    23,848        25,340   1995  2014  40 years
The Laurels of Mt. Vernon  (a)  (4)  Mt. Vernon  OH   225    10,881            225    10,881        11,106   1977  2014  40 years
The Laurels of Norworth  (a)  (4)  Worthington  OH   1,203    15,029            1,203    15,029        16,232   1969  2014  40 years
The Laurels of Shane Hill  (a)  (4)  Rockford  OH   214    13,595            214    13,595        13,809   1971  2014  40 years
Maplewood of Shane’s Village  (b)  (4)  Rockford  OH   47    3,021            47    3,021        3,068   1971  2014  40 years
The Laurels of Worthington  (a)  (4)  Worthington  OH   1,194    9,675            1,194    9,675        10,869   1960  2014  40 years
The Laurels of Bedford  (a)  (4)  Battle Creek  OH   768    11,725            768    11,725        12,493   1974  2014  40 years
The Laurels of Coldwater  (a)  (4)  Coldwater  MI   258    18,705            258    18,705        18,963   1970  2014  40 years
The Laurels of Fulton  (a)  (4)  Perrinton  MI   381    8,057            381    8,057        8,438   1972  2014  40 years
The Laurels of Galesburg  (a)  (4)  Galesburg  MI   326    8,786            326    8,786        9,112   1973  2014  40 years
The Laurels of Hudsonville  (a)  (4)  Hudsonville  MI   178    12,455            178    12,455        12,633   1964  2014  40 years
The Laurels of Kent  (a)  (4)  Lowell  MI   208    15,295            208    15,295        15,503   1972  2014  40 years
The Laurels of Mt. Pleasant  (a)  (4)  Mt. Pleasant  MI   444    10,574            444    10,574        11,018   1964  2014  40 years
The Laurels of Sandy Creek  (a)  (4)  Wayland  MI   995    10,560            995    10,560        11,555   1974  2014  40 years
Maplewood of Sandy Creek  (b)  (4)  Wayland  MI   201    2,133            201    2,133        2,334   1974  2014  40 years
Maplewood of Marshall  (b)  (4)  Marshall  MI   160    10,002            160    10,002        10,162   1997  2014  40 years
Maplewood of Mt. Pleasant  (b)  (4)  Mt. Pleasant  MI   168    7,255            168    7,255        7,423   1989  2014  40 years
Ashewood Manor  (a)  (4)  Asheville  NC   233    4,752            233    4,752        4,985   1990  2014  40 years
The Laurels of Chatham  (a)  (4)  Pittsboro  NC   915    12,656            915    12,656        13,571   1991  2014  40 years
The Laurels of Forest Glenn  (a)  (4)  Garner  NC   1,103    11,763            1,103    11,763        12,866   1991  2014  40 years
The Laurels of Green Tree Ridge  (a)  (4)  Asheville  NC   440    12,110            440    12,110        12,550   1990  2014  40 years
The Laurels of Salisbury  (a)  (4)  Salisbury  NC   447    6,411            447    6,411        6,858   1992  2014  40 years
The Laurels of Summit Ridge  (a)  (4)  Asheville  NC   1,192    17,336            1,192    17,336        18,528   1927  2014  40 years
The Laurels of DeKalb  (a)  (4)  Butler  IN   321    7,703            321    7,703        8,024   1973  2014  40 years
The Laurels of Hendersonville  (a)  (4)  Hendersonville  NC                                     2014  40 years
The Laurels of Willow Creek  (a)  (4)  Midlothian  VA                                     2014  40 years
Westerville Office Building  (j)  (4)  Westerville  OH   1,026    6,712            1,026    6,712        7,738      2014  40 years
Non-Guarantors subtotal               16,081    295,001    13,103    (19,693)   14,630    289,862        304,492          
Maplewood at Danbury  (b)  (5)  Danbury  CT   1,919    14,081    687        1,919    14,768    (1,041)   15,646   1968  2012  40 years
Non-Guarantors, HUD Loan subtotal               1,919    14,081    687        1,919    14,768    (1,041)   15,646          
                188,103    1,670,094    190,314    (101,749)   180,975    1,765,788    (185,788)   1,760,976          

 

F-51
  

  

Assets under direct financing leases

Description  Type of
Asset
  Encum-
brances
  City  State  Initial
Cost to
Company
   Accretion/
Amortization
   Impairment/
Dispositions
   Assets Under
Direct
Financing
Leases
   Net   Year of
Construction
  Date
Acquired
Fountain Lake  (a)  (2)  Hot Springs  AR   10,419    872       $11,291    11,291   2007  2008
               $10,419   $872   $   $11,291   $11,291       

 

Development Properties

 

Description  Type of
Asset
  Encumbrances  City  State  Land   Buildings &
Improvements
      Improvements /
Adjustments
   Construction
in Progress
   Land   Buildings &
Improvements
       Accumulated
Depreciation
   Construction
in Progress
and Land
Held for
Development
   Net  Year of
Construction
  Date
Acquired
    Life on
Which
Depreciation
in Statement
of Operations
Computed
 
Deseret at Mansfield  (b)  (2)  Mansfield  OH   146    2,686         20    293    146    2,706         (597)   293   2,548  1980  2006    40 years  
Care Meridian Escondido  (h)  (2)  Escondido  CA   170    1,139             87    170    1,139         (115)   87   1,281  1990  2011    40 years  
Care Meridian Fresno-Marks  (h)  (2)  Fresno  CA   270    1,709             197    270    1,709         (164)   197   2,012  1990  2011    40 years  
Care Meridian Sacramento  (h)  (2)  Elk Grove  CA   220    1,649             247    220    1,649         (160)   247   1,956  1992  2011    40 years  
Care Meridian Santiago Canyon  (h)  (2)  Silverado  CA   550    1,039             110    550    1,040         (114)   109   1,585  1999  2011    40 years  
Care Meridian Gilroy  (h)  (2)  Gilroy  CA   1,089    1,759             169    1,089    1,761         (168)   167   2,849  2000  2011    40 years  
Twinbrook Nursing & Rehab  (a)  (2)  Louisville  KY   880    8,120             661    880    8,120         (353)   661   9,308  1960  2013    40 years  
Houston Nursing and Rehab  (c)  (2)  Webster  TX   2,110                 256                     2,366   2,366     2014    40 years  
Maplewood at Brewster  (c)  (2)  Brewster  MA   6,288                 3,798                     10,086   10,086     2014    40 years  
Maplewood at Mayflower Place  (b)  (2)  West Yarmouth  MA   3,200    32,800             2,714    3,200    32,800         (440)   2,714   38,274  1988  2014    40 years  
Maplewood at Yarmouth ALZ  (c)  (2)  West Yarmouth  MA   3,784             40    80        40             3,864   3,904     2014    40 years  
Maplewood at Cuyahoga Falls  (c)  (4)  Cuyahoga Falls  OH   1,250                 242                     1,492   1,492     2014    40 years  
Maplewood at Twinsburg  (c)  (4)  Twinsburg  OH   750                 70                     820   820     2014    40 years  
Maplewood at Norumbega Point  (b)  (2)  Weston  MA   2,800    29,200             87    2,800    29,240         (388)   47   31,699  1994  2014    40 years  
               $23,507   $80,102   $   $60   $9,011   $9,325   $80,204        $(2,498)  $23,150   $110,181         
                                        $190,300   $1,845,992   $11,291   $(188,286)  $23,150   $1,882,447              

 

(a) Skilled Nursing Facilities (SNFs)

(b) Assisted Living Facilities (ALFs)

(c) Vacant Land
(d) Assets relating to corporate office space
(e) Developmental asset

(f) Includes six properties all located in Texas

(g) The aggregate cost for federal income tax purposes of the real estate as of December 31, 2014 is $1.8 billion (unaudited).

(h) Traumatic Brain Injury Center (TBIs)

(i) Long Term Acute Care

(j) Medical Office Building

(k) Hospital

 

Encumbrances:     (1)    Issuer
      (2)    Unencumbered guarantors
      (3)    Encumbered guarantors
      (4)    Non guarantors
      (5)    Non guarantor, HUD loan

 

F-52
  

  

AVIV REIT, INC.

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP

 

   For the Years Ended December 31, 
   2014   2013   2012 
Reconciliation of real estate:               
Carrying cost:               
Balance at beginning of period  $1,310,790   $1,102,832   $919,383 
Additions during the period:               
Acquisitions   706,970    199,789    184,326 
Development of rental properties and capital expenditures   60,535    28,415    42,448 
Dispositions:               
Sale of assets   (5,221)   (19,746)   (32,208)
Impairment (i)   (2,341)   (500)   (11,117)
Balance at end of period  $2,070,733   $1,310,790   $1,102,832 
Accumulated depreciation:               
Balance at beginning of period  $147,302   $119,371   $96,796 
Additions during the period:               
Depreciation expense   43,928    33,144    26,810 
Dispositions:               
Sale of assets   (2,944)   (5,213)   (4,235)
Balance at end of period  $188,286   $147,302   $119,371 

 

 

(i) Represents the write-down of carrying cost and accumulated depreciation on assets where impairment charges were taken.